Richmond Mutual Bancorporation (RMBI) 10-Q 13 May 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2022	May 13, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-38956
Entity Registrant Name	RICHMOND MUTUAL BANCORPORATION, INC.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	36-4926041
Entity Address, Address Line One	31 North 9th Street
Entity Address, City or Town	Richmond
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	47374
City Area Code	765
Local Phone Number	962-2581
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	RMBI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		11,954,656
Entity Central Index Key	0001767837
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 8,065,393	$ 8,473,558
Interest-bearing demand deposits	11,510,573	14,564,587
Cash and cash equivalents	19,575,966	23,038,145
Investment securities - available for sale	326,835,054	357,537,845
Investment securities - held to maturity	8,146,327	9,040,825
Loans held for sale	583,000	557,500
Loans and leases, net of allowance for losses of $12,317,000 and $12,108,000, respectively	849,987,070	832,846,017
Premises and equipment, net	14,145,653	14,347,088
Federal Home Loan Bank stock	9,780,900	9,992,400
Interest receivable	4,081,814	4,192,827
Mortgage-servicing rights	1,572,386	1,646,509
Cash surrender value of life insurance	3,640,799	3,619,140
Other assets	17,763,603	10,821,445
Total assets	1,256,112,572	1,267,639,741
Liabilities
Noninterest-bearing deposits	113,661,721	114,302,794
Interest-bearing deposits	795,833,541	785,872,606
Total deposits	909,495,262	900,175,400
Federal Home Loan Bank advances	182,000,000	180,000,000
Advances by borrowers for taxes and insurance	586,547	531,030
Interest payable	289,840	258,032
Other liabilities	6,398,208	6,193,944
Total liabilities	1,098,769,857	1,087,158,406
Commitments and Contingent Liabilities	0	0
Stockholders' Equity
Common stock	123,100	124,002
Additional paid-in capital	113,263,417	114,339,810
Retained earnings	82,037,495	80,157,893
Unearned employee stock ownership plan (ESOP)	(12,744,530)	(12,928,359)
Accumulated other comprehensive loss	(25,336,767)	(1,212,011)
Total stockholders' equity	157,342,715	180,481,335
Total liabilities and stockholders' equity	$ 1,256,112,572	$ 1,267,639,741

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets - Parenthetical - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for loan and lease losses	$ 12,317,000	$ 12,108,000
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	90,000,000	90,000,000
Common stock, shares issued (in shares)	12,310,004	12,400,195
Common stock, shares outstanding (in shares)	12,310,004	12,400,195

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Interest Income
Loans and leases	$ 10,265,959	$ 9,867,278
Investment securities	1,668,651	1,009,239
Other	7,478	6,904
Total interest income	11,942,088	10,883,421
Interest Expense
Deposits	1,248,651	1,187,272
Borrowings	639,823	693,951
Total interest expense	1,888,474	1,881,223
Net Interest Income	10,053,614	9,002,198
Provision for losses on loans and leases	200,000	400,000
Net Interest Income After Provision for Losses on Loans and Leases	9,853,614	8,602,198
Noninterest Income
Service charges on deposit accounts	234,545	194,439
Card fee income	277,770	242,515
Loan and lease servicing fees	27,868	(105,450)
Net gains on loan and lease sales	242,986	964,817
Other income	332,193	231,290
Total noninterest income	1,115,362	1,527,611
Noninterest Expenses
Salaries and employee benefits	4,451,297	4,445,732
Net occupancy expenses	363,533	330,640
Equipment expenses	310,555	336,564
Data processing fees	658,915	526,173
Deposit insurance expense	81,000	71,000
Printing and office supplies	40,284	31,414
Legal and professional fees	347,500	346,518
Advertising expense	92,192	84,044
Bank service charges	29,801	30,751
Real estate owned expense	2,501	2,332
Loss on sale of real estate owned	0	1,278
Other expenses	956,241	771,210
Total noninterest expenses	7,333,819	6,977,656
Income Before Income Tax Expense	3,635,157	3,152,153
Provision for income taxes (includes $0 and $0, respectively, related to income tax expense from reclassification of items)	617,565	589,667
Net Income	$ 3,017,592	$ 2,562,486
Earnings Per Share
Basic (in USD per share)	$ 0.27	$ 0.22
Diluted (in USD per share)	$ 0.26	$ 0.22

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Income - Parenthetical - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Provision for income tax expense from reclassification of items	$ 0	$ 0

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net Income	$ 3,017,592	$ 2,562,486
Other Comprehensive Loss
Unrealized loss on available-for-sale securities, net of tax benefit of $6,412,910, and $972,966, respectively.	(24,124,756)	(3,660,206)
Other comprehensive income, net of tax	(24,124,756)	(3,660,206)
Comprehensive Loss	$ (21,107,164)	$ (1,097,720)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Comprehensive Income - Parenthetical - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Available for sale securities income tax expense (benefit)	$ 6,412,910	$ 972,966

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Unearned ESOP Shares	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2020		13,193,760
Beginning balance at Dec. 31, 2020	$ 192,712,708	$ 131,938	$ 124,246,425	$ 78,290,113	$ (13,664,373)	$ 3,708,605
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,562,486			2,562,486
Other comprehensive loss	(3,660,206)					(3,660,206)
ESOP shares earned	182,705		(1,821)		184,526
Stock based compensation	507,624		507,624
Common stock dividends	(846,947)			(846,947)
Repurchase of common stock (in shares)		(142,764)
Repurchase of common stock	(1,938,736)	$ (1,428)	(1,937,308)
Ending balance (in shares) at Mar. 31, 2021		13,050,996
Ending balance at Mar. 31, 2021	189,519,634	$ 130,510	122,814,920	80,005,652	(13,479,847)	48,399
Beginning balance (in shares) at Dec. 31, 2021		12,400,195
Beginning balance at Dec. 31, 2021	180,481,335	$ 124,002	114,339,810	80,157,893	(12,928,359)	(1,212,011)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,017,592			3,017,592
Other comprehensive loss	(24,124,756)					(24,124,756)
ESOP shares earned	226,121		42,292		183,829
Stock based compensation	379,421		379,421
Common stock dividends	(1,137,990)			(1,137,990)
Repurchase of common stock (in shares)		(90,191)
Repurchase of common stock	(1,499,008)	$ (902)	(1,498,106)
Ending balance (in shares) at Mar. 31, 2022		12,310,004
Ending balance at Mar. 31, 2022	$ 157,342,715	$ 123,100	$ 113,263,417	$ 82,037,495	$ (12,744,530)	$ (25,336,767)

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Changes in Stockholders' Equity - (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Stockholders' Equity [Abstract]
Common stock dividend (in USD per share)	$ 0.10	$ 0.07

Condensed Consolidated Statem_7

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Activities
Net income	$ 3,017,592	$ 2,562,486
Items not requiring (providing) cash
Provision for loan losses	200,000	400,000
Depreciation and amortization	265,213	293,402
Deferred income tax	(72,711)	(93,250)
Stock based compensation	379,421	507,624
Investment securities amortization, net	451,165	712,845
Net gains on loan and lease sales	(242,986)	(964,817)
Loss on sale of real estate owned	0	1,278
Accretion of loan origination fees	(460,332)	(881,097)
Amortization of mortgage-servicing rights	40,748	128,288
ESOP shares expense	226,121	182,705
Increase in cash surrender value of life insurance	(21,659)	(21,361)
Loans originated for sale	(10,784,144)	(27,868,042)
Proceeds on loans sold	10,809,644	26,770,692
Net change in
Interest receivable	111,013	499,613
Other assets	(274,611)	(500,776)
Other liabilities	204,264	(4,151,093)
Interest payable	31,808	(14,225)
Net cash provided by (used in) operating activities	3,880,546	(2,435,728)
Investing Activities
Purchases of securities available for sale	(12,357,092)	(37,779,114)
Proceeds from maturities and paydowns of securities available for sale	12,061,563	18,783,517
Proceeds from maturities and paydowns of securities held to maturity	891,488	2,010,016
Net change in loans	(16,824,787)	(25,020,579)
Proceeds from sales of real estate owned	0	30,270
Purchases of premises and equipment	(63,778)	(119,581)
Proceeds from sale of FHLB stock	211,500	0
Net cash used in investing activities	(16,081,106)	(42,095,471)
Net change in
Demand and savings deposits	23,120,244	50,062,196
Certificates of deposit	(13,800,382)	13,966,055
Advances by borrowers for taxes and insurance	55,517	43,386
Proceeds from FHLB advances	15,000,000	0
Repayment of FHLB advances	(13,000,000)	0
Repurchase of common stock	(1,499,008)	(1,938,736)
Dividends paid	(1,137,990)	(846,947)
Net cash provided by financing activities	8,738,381	61,285,954
Net Change in Cash and Cash Equivalents	(3,462,179)	16,754,755
Cash and Cash Equivalents, Beginning of Period	23,038,145	48,768,457
Cash and Cash Equivalents, End of Period	19,575,966	65,523,212
Additional Cash Flows and Supplementary Information
Interest paid	1,856,666	1,895,448
Transfers from loans to other real estate owned	$ 58,500	$ 0

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial information is unaudited and has been prepared from the consolidated financial statements of Richmond Mutual Bancorporation, Inc., and its wholly owned direct and indirect subsidiaries, First Bank Richmond and FB Richmond Holdings, Inc. References in this document to Richmond Mutual Bancorporation refer to Richmond Mutual Bancorporation, Inc. References to “we,” “us,” and “our” or the “Company” refers to Richmond Mutual Bancorporation and its wholly-owned direct and indirect subsidiaries, First Bank Richmond and FB Richmond Holdings, Inc., unless the context otherwise requires. The accompanying unaudited condensed consolidated financial statements were prepared in accordance with instructions for Form 10-Q and, therefore, do not include information or note disclosures necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with generally accepted accounting principles. Accordingly, these financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission (“SEC”) on March 30, 2022 (SEC File No. 001-38956). However, in the opinion of management, all adjustments which are necessary for a fair presentation of the consolidated financial statements have been included. Those adjustments consist only of normal recurring adjustments. The results of operations for the period are not necessarily indicative of the results to be expected for the full year. Loans For all loan classes, the accrual of interest is discontinued at the time the loan is 90 days past due unless the credit is well-secured and in process of collection. Past due status is based on contractual terms of the loan. For all loan classes, the entire balance of the loan is considered past due if the minimum payment contractually required to be paid is not received by the contractual due date. For all loan classes, loans are placed on nonaccrual or charged off at an earlier date if collection of principal or interest is considered doubtful. The Company charges off residential and consumer loans, or portions thereof, when the Company reasonably determines the amount of the loss. The Company adheres to timeframes established by applicable regulatory guidance, which provides for the charge-down of 1-4 family first and junior lien mortgages to the net realizable value, less costs to sell when the loan is 120 days past due, charge-off of unsecured open-end loans when the loan is 90 days past due, and charge down to the net realizable value when other secured loans are 90 days past due. Loans at these respective delinquency thresholds for which the Company can clearly document that the loan is both well-secured and in the process of collection, such that collection will occur regardless of delinquency status, need not be charged off. For all classes, all interest accrued but not collected for loans that are placed on nonaccrual or charged off is reversed against interest income. The interest on these loans is accounted for on the cash-basis or cost-recovery method, until qualifying for return to accrual. Nonaccrual loans are returned to accrual status when, in the opinion of management, the financial position of the borrower indicates there is no longer any reasonable doubt as to the timely collection of interest or principal. The Company requires a period of satisfactory performance of not less than six months before returning a nonaccrual loan to accrual status. When cash payments are received on impaired loans in each loan class, the Company records the payment as interest income unless collection of the remaining recorded principal amount is doubtful, at which time payments are used to reduce the principal balance of the loan. Troubled debt restructured loans recognize interest income on an accrual basis at the renegotiated rate if the loan is in compliance with the modified terms, no principal reduction has been granted and the loan has demonstrated the ability to perform in accordance with the renegotiated terms for a period of at least six months.

Accounting Pronouncements

Accounting Pronouncements	3 Months Ended
	Mar. 31, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
Accounting Pronouncements	Accounting Pronouncements In March 2020, the novel coronavirus disease of 2019 ("COVID-19") was identified as a global pandemic and began affecting the health of large populations around the world. As a result of the spread of COVID-19, economic uncertainties arose which can ultimately affect the financial position, results of operations and cash flows of the Company, as well as the Company's customers. In response to economic concerns over COVID-19, in March 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was passed into law by the U.S. Congress. The CARES Act included relief for individual Americans, health care workers, small businesses and certain industries hit hard by the COVID-19 pandemic. The 2021 Consolidated Appropriations Act , passed by Congress in December 2020, extended certain provisions of the CARES Act affecting the Company into 2022. The CARES Act included several provisions designed to help financial institutions like the Company in working with their customers. Section 4013 of the CARES Act, as extended, allows a financial institution to elect to suspend generally accepted accounting principles and regulatory determinations with respect to qualifying loan modifications related to COVID-19 that would otherwise be categorized as a troubled debt restructuring ("TDR") until January 1, 2022. The Company has taken advantage of this provision to extend certain payment modifications to loan customers in need. As of March 31, 2022 the Company had no loans outstanding that were modified under the CARES Act guidance. The CARES Act also approved the Paycheck Protection Program ("PPP"), administered by the Small Business Administration ("SBA") with funding provided by financial institutions. The 2021 Consolidated Appropriations Act approved a new round of PPP loans in 2021. The PPP provides loans to eligible businesses through financial institutions like First Bank Richmond, with loans being eligible for forgiveness of some or all of the principal amount by the SBA if the borrower meets certain requirements. The SBA guarantees repayment of the loans if the borrower's loan is not forgiven and is then not repaid by the member. The Company earns a 1% interest rate on PPP loans, plus a processing fee from the SBA for processing and originating a loan. The Company originated approximately $38.2 million in PPP loans during 2021, of which approximately $6.0 million were outstanding at March 31, 2022. The Jumpstart Our Business Startups Act (the "JOBS Act"), enacted in April 2012, has made numerous changes to the federal securities laws to facilitate access to capital markets. Under the JOBS Act, a company with total annual gross revenues of less than $1.07 billion during its most recently completed fiscal year qualifies as an “emerging growth company.” The Company qualifies as and has elected to be an emerging growth company under the JOBS Act. An emerging growth company may elect to comply with new or amended accounting pronouncements in the same manner as a private company, but must make such election when the company is first required to file a registration statement. Such an election is irrevocable during the period a company is an emerging growth company. The Company has elected to comply with new or amended accounting pronouncements in the same manner as a private company. In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments-Credit Losses (Topic 326). The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Organizations will continue to use judgment to determine which loss estimation method is appropriate for their circumstances. The ASU requires enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the financial statements. In May 2019, the FASB issued ASU No. 2019-05, “Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief”. This ASU provides transition relief for entities adopting the FASB’s credit losses standard, ASU 2016-13 and allows companies to irrevocably elect, upon adoption of ASU 2016-13, the fair value option for certain financial instruments. In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments”. ASU No. 2019-04 clarifies certain aspects of accounting for credit losses, hedging activities, and financial instruments. In October 2019, the FASB voted to extend the implementation of ASU No. 2016-13 for certain financial institutions including smaller reporting companies. As a result, ASU 2016-13 will be effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is evaluating its current expected credit loss ("CECL") methodology on the loan and investment portfolios to identify the necessary modifications in accordance with ASU 2016-13. A CECL implementation team consisting of management from multiple areas of the Company have been involved in evaluating loss estimation methods and application of these methods to the specific segments and subsegments of the loan portfolio. Management has been actively monitoring FASB developments and evaluating the use of the different methods allowed. Due to continuing development of our methodology, additional time is required to quantify the effect of CECL on the Company's Consolidated Financial Statements. The Company continues to refine its modeling and will finalize a method or methods of adoption in time for the effective date. In March 2022 the FASB issued ASU 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures . The ASU eliminates the accounting guidance for troubled debt restructured loans (“TDRs”) by creditors while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Additionally, the ASU requires public business entities to disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases. This ASU will be effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, upon the Company’s adoption of the amendments in ASU 2016-13, which is commonly referred to as the current expected credit loss methodology. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU applies to contracts, hedging relationships and other transactions that reference LIBOR or other rate references expected to be discontinued because of reference rate reform. The ASU permits an entity to make necessary modifications to eligible contracts or transactions without requiring contract remeasurement or reassessment of a previous accounting determination. This ASU is effective for all entities as of March 12, 2020 through December 31, 2022. The Company does not expect the adoption of ASU No. 2020-04 to have a material impact on its consolidated financial statements. In October 2020, the FASB issued ASU No. 2020-08, “Receivables – Nonrefundable Fees and Other Costs”. ASU No. 2020-08 clarifies that the Company should reevaluate whether a callable debt security is within the scope of paragraph 310-20-35-33 for each reporting period. ASU No. 2020-08 is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The adoption of ASU No. 2020-08 did not have a material impact on the Company's consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . ASU No. 2019-12 provides that state franchise or similar taxes that are based, at least in part on an entity’s income, be included in an entity’s income tax recognized as income-based taxes. The ASU further clarifies that the effect of any change in tax laws or rates used in the computation of the annual effective tax rate are required to be reflected in the first interim period that includes the enactment date of the legislation. Technical changes to eliminate exceptions to Topic 740 related to intra-period tax allocations for entities with losses from continuing operations, deferred tax liabilities related to change in ownership of foreign entities, and interim-period tax allocations for businesses with losses where the losses are expected to be realized. The amendments in ASU No. 2019-12 are effective for public business entities with fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted ASU No. 2019-12 on January 1, 2021. The adoption of ASU No. 2019-12 did not have a material impact on the Company's consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement . This ASU contains some technical adjustments related to the fair value disclosure requirements of public companies. Included in this ASU is the additional disclosure requirement of unrealized gains and losses for the period in recurring level 3 fair value disclosures and the range and weighted average of significant unobservable inputs, among other technical changes. The Company adopted ASU No. 2018-13 on January 1, 2020. The adoption of ASU No. 2018-13 did not have a material impact on the Company’s consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases

Investment Securities

Investment Securities	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investment Securities	Investment SecuritiesThe amortized cost and approximate fair values, together with gross unrealized gains and losses, of securities are as follows: March 31, 2022 Amortized Gross Gross Fair Available for sale SBA Pools $ 8,232 $ — $ 342 $ 7,890 Federal agencies 15,000 — 1,154 13,846 State and municipal obligations 168,866 65 19,334 149,597 Mortgage-backed securities - government-sponsored enterprises (GSE) residential 156,309 6 11,021 145,294 Corporate obligations 10,500 — 292 10,208 358,907 71 32,143 326,835 Held to maturity State and municipal obligations 8,146 40 19 8,167 8,146 40 19 8,167 Total investment securities $ 367,053 $ 111 $ 32,162 $ 335,002 December 31, 2021 Amortized Gross Gross Fair Available for sale SBA Pools $ 8,691 $ 29 $ 107 $ 8,613 Federal agencies 15,000 — 274 14,726 State and municipal obligations 166,489 2,261 1,298 167,452 Mortgage-backed securities - government-sponsored enterprises (GSE) residential 164,629 712 2,831 162,510 Corporate obligations 4,250 2 28 4,224 Equity securities 13 — — 13 359,072 3,004 4,538 357,538 Held to maturity State and municipal obligations 9,041 147 2 9,186 9,041 147 2 9,186 Total investment securities $ 368,113 $ 3,151 $ 4,540 $ 366,724 The amortized cost and fair value of securities at March 31, 2022, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. Available for Sale Held to Maturity Amortized Fair Amortized Fair Within one year $ 1,159 $ 1,161 $ 1,196 $ 1,199 One to five years 8,668 8,564 4,862 4,868 Five to ten years 44,608 42,636 1,198 1,209 After ten years 148,163 129,180 890 891 202,598 181,541 8,146 8,167 Mortgage-backed securities –GSE residential 156,309 145,294 — — Totals $ 358,907 $ 326,835 $ 8,146 $ 8,167 Securities with a carrying value of $120,074,000 and $136,463,000 were pledged at March 31, 2022 and December 31, 2021, respectively, to secure certain deposits and for other purposes as permitted or required by law. There were no sales of securities available for sale for the three months ended March 31, 2022 and 2021. Certain investments in debt securities, as reflected in the table below, are reported in the condensed consolidated financial statements and notes at an amount less than their historical cost. Total fair value of these investments at March 31, 2022 and December 31, 2021 was $315,723,000 and $223,842,000, respectively, which is approximately 94% and 61% of the Company’s aggregated available-for-sale and held-to-maturity investment portfolio at those dates, respectively. These declines primarily resulted from changes in market interest rates since their purchase. Based on evaluation of available evidence, including recent changes in market interest rates, credit rating information and information obtained from regulatory filings, management believes the declines in fair value for these securities are temporary. Should the impairment of any other securities become other-than-temporary, the cost basis of the investment will be reduced and the resulting loss recognized in net income in the period the other-than-temporary impairment is identified. The following tables show the Company’s investments by gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at March 31, 2022 and December 31, 2021: Description of March 31, 2022 Less Than 12 Months 12 Months or More Total Fair Unrealized Fair Unrealized Fair Unrealized Available-for-sale SBA Pools $ 2,486 $ 110 $ 4,582 $ 232 $ 7,068 $ 342 Federal agencies 9,292 708 4,554 446 13,846 1,154 State and municipal obligations 120,755 15,366 20,615 3,968 141,370 19,334 Mortgage-backed securities - GSE residential 123,280 8,535 20,548 2,486 143,828 11,021 Corporate obligations 8,458 292 — — 8,458 292 Total available-for-sale 264,271 25,011 50,299 7,132 314,570 32,143 Held-to-maturity State and municipal obligations 1,153 19 — — 1,153 19 Total temporarily impaired securities $ 265,424 $ 25,030 $ 50,299 $ 7,132 $ 315,723 $ 32,162 Description of December 31, 2021 Less Than 12 Months 12 Months or More Total Fair Unrealized Fair Unrealized Fair Unrealized Available-for-sale SBA Pools $ 2,838 $ 81 $ 3,214 $ 26 $ 6,052 $ 107 Federal agencies 14,726 274 — — 14,726 274 State and municipal obligations 74,235 1,044 7,809 254 82,044 1,298 Mortgage-backed securities - GSE residential 111,104 2,576 6,523 255 117,627 2,831 Corporate obligations 2,972 28 — — 2,972 28 Total available-for-sale 205,875 4,003 17,546 535 223,421 4,538 Held-to-maturity State and municipal obligations 421 2 — — 421 2 Total temporarily impaired securities $ 206,296 $ 4,005 $ 17,546 $ 535 $ 223,842 $ 4,540 Federal Agency Obligations. The unrealized losses on the Company’s investments in direct obligations of U.S. federal agencies were caused by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. Because the Company does not intend to sell the investments and it is not more likely than not the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2022. SBA Pools and Mortgage-Backed Securities - GSE Residential. The unrealized losses on the Company’s investment in mortgage-backed securities and SBA pools were caused by interest rate changes and illiquidity. The Company expects to recover the amortized cost basis over the term of the securities. Because the decline in fair value is attributable to changes in interest rates and not credit quality, and because the Company does not intend to sell the investments and it is not more likely than not the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2022. State, Municipal, and Corporate Obligations. The unrealized losses on the Company’s investments in securities of state and municipal obligations were caused by interest rate changes and illiquidity. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. Because the Company does not intend to sell the investments and it is not more likely than not the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2022.

Loans, Leases and Allowance

Loans, Leases and Allowance	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Loans, Leases and Allowance	Loans, Leases and Allowance The following table shows the composition of the loan and lease portfolio at March 31, 2022 and December 31, 2021: March 31, December 31, Commercial mortgage $ 257,755 $ 261,202 Commercial and industrial 96,609 99,682 Construction and development 102,123 93,678 Multi-family 116,439 107,421 Residential mortgage 135,155 134,155 Home equity 8,393 7,146 Direct financing leases 130,451 126,762 Consumer 16,130 15,905 863,055 845,951 Less Allowance for loan and lease losses 12,317 12,108 Deferred loan fees 751 997 $ 849,987 $ 832,846 The following tables present the activity in the allowance for loan and lease losses for the three months ended March 31, 2022 and 2021: Balance, beginning of period Provision (credit) for losses Charge-offs Recoveries Balance, end of period Three Months Ended March 31, 2022: Commercial mortgage $ 4,742 $ (19) $ — $ 7 $ 4,730 Commercial and industrial 1,639 (97) — 15 1,557 Construction and development 2,286 148 — — 2,434 Multi-family 1,875 157 — — 2,032 Residential mortgage 263 (6) — 6 263 Home equity 29 6 — — 35 Leases 1,079 (15) (10) 10 1,064 Consumer 195 26 (24) 5 202 Total $ 12,108 $ 200 $ (34) $ 43 $ 12,317 Balance, beginning of period Provision (credit) for losses Charge-offs Recoveries Balance, end of period Three Months Ended March 31, 2021: Commercial mortgage $ 4,628 $ (208) $ — $ 6 $ 4,426 Commercial and industrial 2,270 (50) — 18 2,238 Construction and development 1,068 660 — — 1,728 Multi-family 1,039 3 — — 1,042 Residential mortgage 324 (2) — 6 328 Home equity 18 1 — — 19 Leases 1,054 75 (194) 94 1,029 Consumer 185 (79) (11) 54 149 Total $ 10,586 $ 400 $ (205) $ 178 $ 10,959 The following tables present the balance in the allowance for loan and lease losses and the recorded investment in loans and leases based on portfolio segment and impairment method as of March 31, 2022 and December 31, 2021: Allowance for loan and lease losses: Loans and leases: Individually evaluated for impairment Collectively evaluated for impairment Balance, March 31 Individually evaluated for impairment Collectively evaluated for impairment Balance, March 31 As of March 31, 2022: Commercial mortgage $ — $ 4,730 $ 4,730 $ 116 $ 257,639 $ 257,755 Commercial and industrial 298 1,259 1,557 978 95,631 96,609 Construction and development 750 1,684 2,434 4,900 97,223 102,123 Multi-family — 2,032 2,032 — 116,439 116,439 Residential mortgage — 263 263 117 135,038 135,155 Home equity — 35 35 — 8,393 8,393 Leases — 1,064 1,064 — 130,451 130,451 Consumer — 202 202 — 16,130 16,130 Total $ 1,048 $ 11,269 $ 12,317 $ 6,111 $ 856,944 $ 863,055 Allowance for loan and lease losses: Loans and leases: Individually evaluated for impairment Collectively evaluated for impairment Balance, December 31 Individually evaluated for impairment Collectively evaluated for impairment Balance, December 31 As of December 31, 2021: Commercial mortgage $ — $ 4,742 $ 4,742 $ 128 $ 261,074 $ 261,202 Commercial and industrial 299 1,340 1,639 995 98,687 99,682 Construction and development 750 1,536 2,286 4,900 88,778 93,678 Multi-family — 1,875 1,875 — 107,421 107,421 Residential mortgage — 263 263 119 134,036 134,155 Home equity — 29 29 — 7,146 7,146 Leases — 1,079 1,079 — 126,762 126,762 Consumer — 195 195 — 15,905 15,905 Total $ 1,049 $ 11,059 $ 12,108 $ 6,142 $ 839,809 $ 845,951 The Company rates all loans and leases by credit quality using the following designations: Grade 1 – Exceptional Exceptional loans and leases are top-quality loans to individuals whose financial credentials are well known to the Company. These loans and leases have excellent sources of repayment, are well documented and/or virtually free of risk (i.e., CD secured loans). Grade 2 – Quality Loans and Leases These loans and leases have excellent sources of repayment with no identifiable risk of collection, and they conform in all respects to Company policy and Indiana Department of Financial Institutions (“IDFI”) and Federal Deposit Insurance Corporation (“FDIC”) regulations. Documentation exceptions are minimal or are in the process of being corrected and are not of a type that could subsequently expose the Company to risk of loss. Grade 3 – Acceptable Loans This category is for “average” quality loans and leases. These loans and leases have adequate sources of repayment with little identifiable risk of collection and they conform to Company policy and IDFI/FDIC regulations. Grade 4 – Acceptable but Monitored Loans and leases in this category may have a greater than average risk due to financial weakness or uncertainty but do not appear to require classification as special mention or substandard loans. Loans and leases rated “4” need to be monitored on a regular basis to ascertain that the reasons for placing them in this category do not advance or worsen. Grade 5 – Special Mention Loans and leases in this category have potential weaknesses that deserve management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or lease or in the Company’s credit position at some future date. Special Mention loans and leases are not adversely classified and do not expose the Company to sufficient risk to warrant adverse classification. This special mention rating is designed to identify a specific level of risk and concern about an asset’s quality. Although a special mention loan or leases has a higher probability of default than a pass rated loan or lease, its default is not imminent. Grade 6 – Substandard Loans and leases in this category are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans and leases so classified must have a well-defined weakness, or weaknesses, that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected. Substandard loans and leases have a high probability of payment default, or they have other well-defined weaknesses. Such loans and leases have a distinct potential for loss; however, an individual loan’s or lease’s potential for loss does not have to be distinct for the loan or lease to be rated substandard. The following are examples of situations that might cause a loan or lease to be graded a “6”: • Cash flow deficiencies (losses) jeopardize future loan or lease payments. • Sale of non-collateral assets has become a primary source of loan or lease repayment. • The relationship has deteriorated to the point that sale of collateral is now the Company’s primary source of repayment, unless this was the original source of loan or lease repayment. • The borrower is bankrupt or for any other reason future repayment is dependent on court action. Grade 7 – Doubtful A loan or lease classified as doubtful has all the weaknesses inherent in one classified substandard with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of current existing facts, conditions, and values, highly questionable and improbable. A doubtful loan or lease has a high probability of total or substantial loss. Doubtful borrowers are usually in default, lack adequate liquidity or capital, and lack the resources necessary to remain an operating entity. Because of high probability of loss, nonaccrual accounting treatment will be required for doubtful loans and leases. Grade 8 – Loss Loans and leases classified loss are considered uncollectible and of such little value that their continuance as bankable assets is not warranted. This classification does not mean that the loan or lease has absolutely no recovery or salvage value, but rather that it is not practical or desirable to defer writing off the loan or lease even though partial recovery may be effected in the future. No material changes have been made to the risk characteristics pertaining to the loan and lease portfolio contained in the Company's 2021 Form 10-K. The following tables present the credit risk profile of the Company’s loan and lease portfolio based on rating category and payment activity as of March 31, 2022 and December 31, 2021: Pass Special Mention Substandard Doubtful Loss Total As of March 31, 2022: Commercial mortgage $ 252,647 $ 4,992 $ 116 $ — $ — $ 257,755 Commercial and industrial 88,227 7,032 1,350 — — 96,609 Construction and development 97,223 — 4,900 — — 102,123 Multi-family 116,439 — — — — 116,439 Residential mortgage 133,294 — 1,861 — — 135,155 Home equity 8,327 — 66 — — 8,393 Leases 130,308 — 97 46 — 130,451 Consumer 16,112 — 18 — — 16,130 Total $ 842,577 $ 12,024 $ 8,408 $ 46 $ — $ 863,055 Pass Special Mention Substandard Doubtful Loss Total As of December 31, 2021: Commercial mortgage $ 256,043 $ 5,031 $ 128 $ — $ — $ 261,202 Commercial and industrial 91,082 7,191 1,409 — — 99,682 Construction and development 88,778 — 4,900 — — 93,678 Multi-family 107,421 — — — — 107,421 Residential mortgage 132,223 — 1,932 — — 134,155 Home equity 7,097 — 49 — — 7,146 Leases 126,707 — 13 42 — 126,762 Consumer 15,883 — 22 — — 15,905 Total $ 825,234 $ 12,222 $ 8,453 $ 42 $ — $ 845,951 The following tables present the Company’s loan and lease portfolio aging analysis of the recorded investment in loans and leases as of March 31, 2022 and December 31, 2021: March 31, 2022 Delinquent Loans and Leases Current Total Total Loans 30-59 Days 60-89 Days 90 Days and Total Past Commercial mortgage $ 27 $ 418 $ 116 $ 561 $ 257,194 $ 257,755 $ — Commercial and industrial 387 570 367 1,324 95,285 96,609 — Construction and development 96 — 4,900 4,996 97,127 102,123 — Multi-family — — — — 116,439 116,439 — Residential mortgage 647 360 1,861 2,868 132,287 135,155 1,745 Home equity 120 — 31 151 8,242 8,393 31 Leases 86 152 — 238 130,213 130,451 — Consumer 88 59 18 165 15,965 16,130 18 Totals $ 1,451 $ 1,559 $ 7,293 $ 10,303 $ 852,752 $ 863,055 $ 1,794 December 31, 2021 Delinquent Loans and Leases Current Total Total Loans 30-59 Days 60-89 Days 90 Days and Total Past Commercial mortgage $ 29 $ — $ 128 $ 157 $ 261,045 $ 261,202 $ — Commercial and industrial 33 579 366 978 98,704 99,682 — Construction and development 55 96 4,900 5,051 88,627 93,678 — Multi-family — — — — 107,421 107,421 — Residential mortgage 710 174 1,932 2,816 131,339 134,155 1,813 Home equity 131 — 12 143 7,003 7,146 12 Leases 144 82 — 226 126,536 126,762 — Consumer 59 30 22 111 15,794 15,905 22 Totals $ 1,161 $ 961 $ 7,360 $ 9,482 $ 836,469 $ 845,951 $ 1,847 The following tables present the Company’s impaired loans and specific valuation allowance at March 31, 2022 and December 31, 2021: March 31, 2022 Recorded Unpaid Specific Impaired loans without a specific valuation allowance Commercial mortgage $ 116 $ 199 $ — Commercial and industrial 366 566 — Residential mortgage 117 243 — $ 599 $ 1,008 $ — Impaired loans with a specific valuation allowance Commercial and industrial $ 612 $ 648 $ 298 Construction and development 4,900 4,900 750 $ 5,512 $ 5,548 $ 1,048 Total impaired loans Commercial mortgage $ 116 $ 199 $ — Commercial and industrial 978 1,214 298 Construction and development 4,900 4,900 750 Residential mortgage 117 243 — Total impaired loans $ 6,111 $ 6,556 $ 1,048 December 31, 2021 Recorded Unpaid Specific Impaired loans without a specific valuation allowance Commercial mortgage $ 128 $ 199 $ — Commercial and industrial 367 566 — Residential mortgage 119 244 — $ 614 $ 1,009 $ — Impaired loans with a specific valuation allowance Commercial and industrial $ 628 $ 658 $ 299 Construction and development 4,900 4,900 750 $ 5,528 $ 5,558 $ 1,049 Total impaired loans Commercial mortgage $ 128 $ 199 $ — Commercial and industrial 995 1,224 299 Construction and development 4,900 4,900 750 Residential mortgage 119 244 — Total impaired loans $ 6,142 $ 6,567 $ 1,049 The following tables present the Company’s average investment in impaired loans and leases, and interest income recognized for the three months ended March 31, 2022 and 2021: Average Interest Three Months Ended March 31, 2022: Total impaired loans Commercial mortgage $ 122 $ 12 Commercial and industrial 987 7 Construction and development 4,900 — Residential mortgage 118 1 Total impaired loans and leases $ 6,127 $ 20 Average Interest Three Months Ended March 31, 2021: Total impaired loans Commercial mortgage $ 76 $ — Commercial and industrial 1,086 10 Construction and development 2,450 — Residential mortgage 180 2 Total impaired loans and leases $ 3,792 $ 12 The following table presents the Company’s nonaccrual loans and leases at March 31, 2022 and December 31, 2021: March 31, December 31, Commercial mortgage $ 116 $ 128 Commercial and industrial 978 995 Construction 4,900 4,900 Residential mortgage 117 119 Leases 46 42 $ 6,157 $ 6,184 During the three months ended March 31, 2022 and 2021, there were no newly classified TDRs. For the three months ended March 31, 2022 and 2021, the Company recorded no charge-offs related to TDRs. As of March 31, 2022 and December 31, 2021, TDRs had a related allowance of $48,000 and $49,000, respectively. During the three months ended March 31, 2022, there were no TDRs for which there was a payment default within the first 12 months of the modification. The CARES Act provided guidance around the modification of loans as a result of the COVID-19 pandemic, which outlined, among other criteria, that short-term modifications made on a good faith basis to borrowers who were current as defined under the CARES Act prior to any relief, are not TDRs. This includes short-term (e.g. six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. Borrowers are considered current under the CARES Act if they are less than 30 days past due on their contractual payments at the time a modification program is implemented. In March 2020, the Company began offering short-term loan modifications to assist borrowers during the COVID-19 pandemic. As of March 31, 2022, the Company had no loan and lease modifications outstanding related to the COVID-19 pandemic in accordance with the CARES Act. At March 31, 2022 and December 31, 2021, the balance of real estate owned included $86,000 and $27,000, respectively, of foreclosed residential real estate properties recorded as a result of obtaining physical possession of the property. At March 31, 2022 and December 31, 2021, the recorded investment of consumer mortgage loans secured by residential real estate properties for which formal foreclosure proceeds were in process was $885,000 and $885,000, respectively. The following lists the components of the net investment in direct financing leases: March 31, December 31, Total minimum lease payments to be received $ 143,600 $ 140,214 Initial direct costs 7,870 7,035 151,470 147,249 Less: Unearned income (21,019) (20,487) Net investment in direct finance leases $ 130,451 $ 126,762 There were no leases serviced by the Company for the benefit of others at March 31, 2022 and December 31, 2021. Certain leases have been sold from time to time by the Company with partial recourse. The Company estimates and records its obligation based upon historical loss percentages. At both March 31, 2022 and December 31, 2021, the Company did not have any recorded recourse obligations on leases sold. The following table summarizes the future minimum lease payments receivable subsequent to March 31, 2022: 2022 $ 41,326 2023 43,736 2024 31,387 2025 18,375 2026 7,858 Thereafter 918 $ 143,600

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements must maximize the use of observable inputs and minimize the use of unobservable inputs. There is a hierarchy of three levels of inputs that may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets or liabilities Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities Level 3 Unobservable inputs supported by little or no market activity that are significant to the fair value of the assets or liabilities Recurring Measurements The following tables present the fair value measurements of assets recognized in the accompanying consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2022 and December 31, 2021: Fair Value Measurements Using Fair Quoted Prices Significant Significant March 31, 2022 Available-for-sale securities SBA Pools $ 7,890 $ — $ 7,890 $ — Federal agencies 13,846 — 13,846 — State and municipal obligations 149,597 — 149,597 — Mortgage-backed securities - GSE residential 145,294 — 145,294 — Corporate obligations 10,208 — 10,208 — $ 326,835 $ — $ 326,835 $ — Fair Value Measurements Using Fair Quoted Prices Significant Significant December 31, 2021 Available-for-sale securities SBA Pools $ 8,613 $ — $ 8,613 $ — Federal agencies 14,726 — 14,726 — State and municipal obligations 167,452 — 167,452 — Mortgage-backed securities - GSE residential 162,510 — 162,510 — Corporate obligations 4,224 — 4,224 — Equity securities 13 13 — — $ 357,538 $ 13 $ 357,525 $ — Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy. There have been no significant changes in the valuation techniques during the three months ended March 31, 2022. Available-for-Sale Securities Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy, which includes equity securities. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. Level 2 securities include agency securities, obligations of state and political subdivisions, and mortgage-backed securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but rather relying on the investment securities’ relationship to other benchmark quoted investment securities. In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Nonrecurring Measurements The following table presents the fair value measurement of assets and liabilities measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2022 and December 31, 2021: Fair Value Measurements Using Fair Quoted Prices Significant Significant March 31, 2022 Impaired loans, collateral dependent $ 314 $ — $ — $ 314 Mortgage-servicing rights 1,572 — — 1,572 December 31, 2021 Impaired loans, collateral dependent $ 4,587 $ — $ — $ 4,587 Mortgage-servicing rights 1,647 — — 1,647 Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis and recognized in the accompanying consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy. For assets classified within Level 3 of the fair value hierarchy, the process used to develop the reported fair value is described below. Collateral-Dependent Impaired Loans, Net of ALLL The estimated fair value of collateral-dependent impaired loans is based on the appraised fair value of the collateral, less estimated cost to sell. Collateral-dependent impaired loans are classified within Level 3 of the fair value hierarchy. The Company considers the appraisal or evaluation as the starting point for determining fair value and then considers other factors and events in the environment that may affect the fair value. Appraisals of the collateral underlying collateral-dependent loans are obtained when the loan is determined to be collateral-dependent and subsequently as deemed necessary by management. Appraisals are reviewed for accuracy and consistency by management. Appraisers are selected from the list of approved appraisers maintained by management. The appraised values are reduced by discounts to consider lack of marketability and estimated cost to sell if repayment or satisfaction of the loan is dependent on the sale of the collateral. These discounts and estimates are developed by management by comparison to historical results. Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. Allowable methods for determining the amount of impairment include estimating fair value using the fair value of the collateral for collateral-dependent loans. Mortgage-Servicing Rights Mortgage-servicing rights do not trade in an active, open market with readily observable prices. Accordingly, fair value is estimated using discounted cash flow models having significant inputs of discount rate, prepayment speed and default rate. Due to the nature of the valuation inputs, mortgage-servicing rights are classified within Level 3 of the hierarchy. Mortgage-servicing rights are tested for impairment on a quarterly basis based on an independent valuation. The valuation is reviewed by management for accuracy and for potential impairment. Unobservable (Level 3) Inputs The following tables present the fair value measurement of assets recognized in the accompanying consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2022 and December 31, 2021: Fair Value at March 31, Valuation Unobservable Range Collateral-dependent impaired loans $ 314 Appraisal Marketability discount 0 - 42% Mortgage-servicing rights $ 1,572 Discounted cash flow Discount rate 10% Fair Value at December 31, Valuation Unobservable Range Collateral-dependent impaired loans $ 4,587 Appraisal Marketability discount 0 - 39% Mortgage-servicing rights $ 1,647 Discounted cash flow Discount rate 10% Fair Value of Financial Instruments The following tables present estimated fair values of the Company’s financial instruments at March 31, 2022 and December 31, 2021: Fair Value Measurements Using Carrying Quoted Prices Significant Significant March 31, 2022 Financial assets Cash and cash equivalents $ 19,576 $ 19,576 $ — $ — Available-for-sale securities 326,835 — 326,835 — Held-to-maturity securities 8,146 — 8,167 — Loans held for sale 583 — — 579 Loans and leases receivable, net 849,987 — — 849,749 Federal Reserve and FHLB stock 9,781 — 9,781 — Interest receivable 4,082 — 4,082 — Financial liabilities Deposits 909,495 — 907,798 — FHLB advances 182,000 — 184,801 — Interest payable 290 — 290 — Fair Value Measurements Using Carrying Quoted Prices Significant Significant December 31, 2021 Financial assets Cash and cash equivalents $ 23,038 $ 23,038 $ — $ — Available-for-sale securities 357,538 13 357,525 — Held-to-maturity securities 9,041 — 9,186 — Loans held for sale 558 — — 555 Loans and leases receivable, net 832,846 — — 833,975 Federal Reserve and FHLB stock 9,992 — 9,992 — Interest receivable 4,193 — 4,193 — Financial liabilities Deposits 900,175 — 900,528 — FHLB advances 180,000 — 185,065 — Interest payable 258 — 258 —

Earnings per Share

Earnings per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic EPS is computed by dividing net income allocated to common stock by the weighted average number of common shares outstanding during the period which excludes the participating securities. Diluted EPS includes the dilutive effect of additional potential common shares from stock compensation awards, but excludes awards considered participating securities. ESOP shares are not considered outstanding for EPS until they are earned. The following table presents the computation of basic and diluted EPS for the periods indicated: Three Months Ended March 31, 2022 Three Months Ended March 31, 2021 Net income $ 3,018 $ 2,562 Shares outstanding for Basic EPS: Average shares outstanding 12,347,125 13,124,015 Less: average restricted stock award shares not vested 348,395 431,501 Less: average unearned ESOP Shares 951,205 1,005,311 Shares outstanding for Basic EPS 11,047,525 11,687,203 Additional Dilutive Shares 426,940 176,705 Shares outstanding for Diluted EPS 11,474,465 11,863,908 Basic Earnings Per Share $ 0.27 $ 0.22 Diluted Earnings Per Share $ 0.26 $ 0.22

Benefit Plans

Benefit Plans	3 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans 401(k) The Company has a retirement savings 401(k) plan, in which substantially all employees may participate. The Company matches employees' contributions at the rate of 50 percent for the first six percent of base salary contributed by participants. The Company’s expense for the plan was $53,000 and $52,000 for the three months ended March 31, 2022 and 2021, respectively. Employee Stock Ownership Plan As part of the reorganization and related stock offering, the Company established an Employee Stock Ownership Plan, or ESOP, covering substantially all employees. The ESOP acquired 1,082,130 shares of Company common stock at an average price of $13.59 per share on the open market with funds provided by a loan from the Company. Dividends on unallocated shares used to repay the loan for the Company are recorded as a reduction of the loan or accrued interest, as applicable. Dividends on allocated shares paid to participants are reported as compensation expense. Unearned ESOP shares which have not yet been allocated to ESOP participants are excluded from the computation of average shares outstanding for earnings per share calculation. Accordingly, $12,744,530 and $12,928,359 of common stock acquired by the ESOP was shown as a reduction of stockholders’ equity at March 31, 2022 and December 31, 2021, respectively. Shares are released to participants proportionately as the loan is repaid. ESOP expense for the three months ended March 31, 2022 and 2021 was $226,000 and $183,000, respectively. March 31, December 31, Earned ESOP shares 144,302 130,775 Unearned ESOP shares 937,828 951,355 Total ESOP shares 1,082,130 1,082,130 Quoted per share price $ 17.06 $ 16.05 Fair value of earned shares $ 2,462 $ 2,099 Fair value of unearned shares $ 15,999 $ 15,269 Richmond Mutual Bancorporation, Inc. 2020 Equity Incentive Plan On September 15, 2020, the Company's stockholders approved the Richmond Mutual Bancorporation, Inc. 2020 Equity Incentive Plan ("2020 EIP") which provides for the grant to eligible participants of up to (i) 1,352,662 shares of Company common stock to be issued upon the exercise of stock options and stock appreciation rights and (ii) 541,065 shares of Company common stock to participants as restricted stock awards (which may be in the form of shares of common stock or share units giving the participant the right to receive shares of common stock at a specified future date). Restricted Stock Awards . On October 1, 2020, the Company awarded 449,086 shares of common stock under the 2020 EIP with a grant date fair value of $10.53 per share (total fair value of $4.7 million at issuance) to eligible participants. On April 1, 2021, the Company awarded an additional 4,000 shares of common stock under the 2020 EIP with a grant date fair value of $13.86 (total fair value of $55,000 at issuance) to eligible participants. These awards vest in five equal annual installments with the first vesting occurring on June 30, 2021. Forfeited shares may be awarded to other eligible recipients in future grants until the 2020 EIP terminates in September 2030. The following table summarizes the restricted stock awards activity in the 2020 EIP during the three months ended March 31, 2022. Three Months Ended March 31, 2022 Number of Restricted Shares Weighted Average Grant Date Fair Value Non-vested, beginning of period 348,395 $ 10.56 Granted — — Vested — — Forfeited — — Non-vested, March 31, 2022 348,395 10.56 Total compensation cost recognized in the income statement for restricted stock awards during the three months ended March 31, 2022 was $226,000, and the related tax benefit recognized was $48,000. As of March 31, 2022, unrecognized compensation expense related to restricted stock awards was $3.0 million. Stock Option Plan. On October 1, 2020, the Company awarded options to purchase 1,095,657 of common stock under the 2020 EIP with an exercise price of $10.53 per share, the fair value of a share of the Company's common stock on the date of grant, to eligible participants. On April 1, 2021, the Company awarded options to purchase 8,000 shares of common stock under the 2020 EIP with an exercise price of $13.86 per share, the fair value of a share of the Company's common stock on the date of the grant, to eligible participants. These options awarded vest in five equal annual installments with the first vesting occurring on June 30, 2021. Forfeited options may be awarded to other eligible recipients in future grants until the 2020 EIP terminates in September 2030. The following table summarizes the stock option activity in the 2020 EIP during the three months ended March 31, 2022. Three Months Ended March 31, 2022 Number of Shares Weighted-Average Exercise Price Balance at beginning of period 1,050,961 $ 10.56 Granted — — Exercised — — Forfeited/expired — — Balance, March 31, 2022 1,050,961 10.56 Exercisable at end of period 200,503 $ 10.56 The fair value of options granted is estimated on the date of the grant using a Black Scholes model with the following assumptions: April 1, 2021 Dividend yields 1.90 % Volatility factors of expected market price of common stock 26.98 % Risk-free interest rates 1.16 % Expected life of options 6.1 years A summary of the status of the Company stock option shares as of March 31, 2022 is presented below. Shares Weighted Average Grant Date Fair Value Non-vested, beginning of year 850,458 $ 2.91 Vested — — Granted — — Forfeited — — Non-vested, March 31, 2022 850,458 $ 2.91 Total compensation cost recognized in the income statement for option-based payment arrangements for the three months ended March 31, 2022 was $153,000, and the related tax benefit recognized was $17,000. As of March 31, 2022, unrecognized compensation expense related to the stock option awards was $2.0 million.

Subsequent Event

Subsequent Event	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Event	Subsequent EventSubsequent to March 31, 2022 through May 13, 2022 the Company purchased 355,348 shares of the Company's common stock pursuant to the existing stock repurchase program, leaving 554,014 shares available for future repurchase.

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Loans	Loans For all loan classes, the accrual of interest is discontinued at the time the loan is 90 days past due unless the credit is well-secured and in process of collection. Past due status is based on contractual terms of the loan. For all loan classes, the entire balance of the loan is considered past due if the minimum payment contractually required to be paid is not received by the contractual due date. For all loan classes, loans are placed on nonaccrual or charged off at an earlier date if collection of principal or interest is considered doubtful. The Company charges off residential and consumer loans, or portions thereof, when the Company reasonably determines the amount of the loss. The Company adheres to timeframes established by applicable regulatory guidance, which provides for the charge-down of 1-4 family first and junior lien mortgages to the net realizable value, less costs to sell when the loan is 120 days past due, charge-off of unsecured open-end loans when the loan is 90 days past due, and charge down to the net realizable value when other secured loans are 90 days past due. Loans at these respective delinquency thresholds for which the Company can clearly document that the loan is both well-secured and in the process of collection, such that collection will occur regardless of delinquency status, need not be charged off. For all classes, all interest accrued but not collected for loans that are placed on nonaccrual or charged off is reversed against interest income. The interest on these loans is accounted for on the cash-basis or cost-recovery method, until qualifying for return to accrual. Nonaccrual loans are returned to accrual status when, in the opinion of management, the financial position of the borrower indicates there is no longer any reasonable doubt as to the timely collection of interest or principal. The Company requires a period of satisfactory performance of not less than six months before returning a nonaccrual loan to accrual status. When cash payments are received on impaired loans in each loan class, the Company records the payment as interest income unless collection of the remaining recorded principal amount is doubtful, at which time payments are used to reduce the principal balance of the loan. Troubled debt restructured loans recognize interest income on an accrual basis at the renegotiated rate if the loan is in compliance with the modified terms, no principal reduction has been granted and the loan has demonstrated the ability to perform in accordance with the renegotiated terms for a period of at least six months.
Accounting Pronouncements	Accounting Pronouncements In March 2020, the novel coronavirus disease of 2019 ("COVID-19") was identified as a global pandemic and began affecting the health of large populations around the world. As a result of the spread of COVID-19, economic uncertainties arose which can ultimately affect the financial position, results of operations and cash flows of the Company, as well as the Company's customers. In response to economic concerns over COVID-19, in March 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was passed into law by the U.S. Congress. The CARES Act included relief for individual Americans, health care workers, small businesses and certain industries hit hard by the COVID-19 pandemic. The 2021 Consolidated Appropriations Act , passed by Congress in December 2020, extended certain provisions of the CARES Act affecting the Company into 2022. The CARES Act included several provisions designed to help financial institutions like the Company in working with their customers. Section 4013 of the CARES Act, as extended, allows a financial institution to elect to suspend generally accepted accounting principles and regulatory determinations with respect to qualifying loan modifications related to COVID-19 that would otherwise be categorized as a troubled debt restructuring ("TDR") until January 1, 2022. The Company has taken advantage of this provision to extend certain payment modifications to loan customers in need. As of March 31, 2022 the Company had no loans outstanding that were modified under the CARES Act guidance. The CARES Act also approved the Paycheck Protection Program ("PPP"), administered by the Small Business Administration ("SBA") with funding provided by financial institutions. The 2021 Consolidated Appropriations Act approved a new round of PPP loans in 2021. The PPP provides loans to eligible businesses through financial institutions like First Bank Richmond, with loans being eligible for forgiveness of some or all of the principal amount by the SBA if the borrower meets certain requirements. The SBA guarantees repayment of the loans if the borrower's loan is not forgiven and is then not repaid by the member. The Company earns a 1% interest rate on PPP loans, plus a processing fee from the SBA for processing and originating a loan. The Company originated approximately $38.2 million in PPP loans during 2021, of which approximately $6.0 million were outstanding at March 31, 2022. The Jumpstart Our Business Startups Act (the "JOBS Act"), enacted in April 2012, has made numerous changes to the federal securities laws to facilitate access to capital markets. Under the JOBS Act, a company with total annual gross revenues of less than $1.07 billion during its most recently completed fiscal year qualifies as an “emerging growth company.” The Company qualifies as and has elected to be an emerging growth company under the JOBS Act. An emerging growth company may elect to comply with new or amended accounting pronouncements in the same manner as a private company, but must make such election when the company is first required to file a registration statement. Such an election is irrevocable during the period a company is an emerging growth company. The Company has elected to comply with new or amended accounting pronouncements in the same manner as a private company. In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments-Credit Losses (Topic 326). The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Organizations will continue to use judgment to determine which loss estimation method is appropriate for their circumstances. The ASU requires enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the financial statements. In May 2019, the FASB issued ASU No. 2019-05, “Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief”. This ASU provides transition relief for entities adopting the FASB’s credit losses standard, ASU 2016-13 and allows companies to irrevocably elect, upon adoption of ASU 2016-13, the fair value option for certain financial instruments. In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments”. ASU No. 2019-04 clarifies certain aspects of accounting for credit losses, hedging activities, and financial instruments. In October 2019, the FASB voted to extend the implementation of ASU No. 2016-13 for certain financial institutions including smaller reporting companies. As a result, ASU 2016-13 will be effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is evaluating its current expected credit loss ("CECL") methodology on the loan and investment portfolios to identify the necessary modifications in accordance with ASU 2016-13. A CECL implementation team consisting of management from multiple areas of the Company have been involved in evaluating loss estimation methods and application of these methods to the specific segments and subsegments of the loan portfolio. Management has been actively monitoring FASB developments and evaluating the use of the different methods allowed. Due to continuing development of our methodology, additional time is required to quantify the effect of CECL on the Company's Consolidated Financial Statements. The Company continues to refine its modeling and will finalize a method or methods of adoption in time for the effective date. In March 2022 the FASB issued ASU 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures . The ASU eliminates the accounting guidance for troubled debt restructured loans (“TDRs”) by creditors while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Additionally, the ASU requires public business entities to disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases. This ASU will be effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, upon the Company’s adoption of the amendments in ASU 2016-13, which is commonly referred to as the current expected credit loss methodology. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU applies to contracts, hedging relationships and other transactions that reference LIBOR or other rate references expected to be discontinued because of reference rate reform. The ASU permits an entity to make necessary modifications to eligible contracts or transactions without requiring contract remeasurement or reassessment of a previous accounting determination. This ASU is effective for all entities as of March 12, 2020 through December 31, 2022. The Company does not expect the adoption of ASU No. 2020-04 to have a material impact on its consolidated financial statements. In October 2020, the FASB issued ASU No. 2020-08, “Receivables – Nonrefundable Fees and Other Costs”. ASU No. 2020-08 clarifies that the Company should reevaluate whether a callable debt security is within the scope of paragraph 310-20-35-33 for each reporting period. ASU No. 2020-08 is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The adoption of ASU No. 2020-08 did not have a material impact on the Company's consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . ASU No. 2019-12 provides that state franchise or similar taxes that are based, at least in part on an entity’s income, be included in an entity’s income tax recognized as income-based taxes. The ASU further clarifies that the effect of any change in tax laws or rates used in the computation of the annual effective tax rate are required to be reflected in the first interim period that includes the enactment date of the legislation. Technical changes to eliminate exceptions to Topic 740 related to intra-period tax allocations for entities with losses from continuing operations, deferred tax liabilities related to change in ownership of foreign entities, and interim-period tax allocations for businesses with losses where the losses are expected to be realized. The amendments in ASU No. 2019-12 are effective for public business entities with fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted ASU No. 2019-12 on January 1, 2021. The adoption of ASU No. 2019-12 did not have a material impact on the Company's consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement . This ASU contains some technical adjustments related to the fair value disclosure requirements of public companies. Included in this ASU is the additional disclosure requirement of unrealized gains and losses for the period in recurring level 3 fair value disclosures and the range and weighted average of significant unobservable inputs, among other technical changes. The Company adopted ASU No. 2018-13 on January 1, 2020. The adoption of ASU No. 2018-13 did not have a material impact on the Company’s consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases
Federal Agencies	Federal Agency Obligations. The unrealized losses on the Company’s investments in direct obligations of U.S. federal agencies were caused by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. Because the Company does not intend to sell the investments and it is not more likely than not the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2022.
Mortgage-Backed Securities - GSE Residential and SBA Pools	.  The unrealized losses on the Company’s investment in mortgage-backed securities and SBA pools were caused by interest rate changes and illiquidity.  The Company expects to recover the amortized cost basis over the term of the securities.  Because the decline in fair value is attributable to changes in interest rates and not credit quality, and because the Company does not intend to sell the investments and it is not more likely than not the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2022.
State and Municipal Obligations	State, Municipal, and Corporate Obligations. The unrealized losses on the Company’s investments in securities of state and municipal obligations were caused by interest rate changes and illiquidity. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. Because the Company does not intend to sell the investments and it is not more likely than not the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2022.
Credit Quality Indicators and Characteristics	The Company rates all loans and leases by credit quality using the following designations: Grade 1 – Exceptional Exceptional loans and leases are top-quality loans to individuals whose financial credentials are well known to the Company. These loans and leases have excellent sources of repayment, are well documented and/or virtually free of risk (i.e., CD secured loans). Grade 2 – Quality Loans and Leases These loans and leases have excellent sources of repayment with no identifiable risk of collection, and they conform in all respects to Company policy and Indiana Department of Financial Institutions (“IDFI”) and Federal Deposit Insurance Corporation (“FDIC”) regulations. Documentation exceptions are minimal or are in the process of being corrected and are not of a type that could subsequently expose the Company to risk of loss. Grade 3 – Acceptable Loans This category is for “average” quality loans and leases. These loans and leases have adequate sources of repayment with little identifiable risk of collection and they conform to Company policy and IDFI/FDIC regulations. Grade 4 – Acceptable but Monitored Loans and leases in this category may have a greater than average risk due to financial weakness or uncertainty but do not appear to require classification as special mention or substandard loans. Loans and leases rated “4” need to be monitored on a regular basis to ascertain that the reasons for placing them in this category do not advance or worsen. Grade 5 – Special Mention Loans and leases in this category have potential weaknesses that deserve management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or lease or in the Company’s credit position at some future date. Special Mention loans and leases are not adversely classified and do not expose the Company to sufficient risk to warrant adverse classification. This special mention rating is designed to identify a specific level of risk and concern about an asset’s quality. Although a special mention loan or leases has a higher probability of default than a pass rated loan or lease, its default is not imminent. Grade 6 – Substandard Loans and leases in this category are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans and leases so classified must have a well-defined weakness, or weaknesses, that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected. Substandard loans and leases have a high probability of payment default, or they have other well-defined weaknesses. Such loans and leases have a distinct potential for loss; however, an individual loan’s or lease’s potential for loss does not have to be distinct for the loan or lease to be rated substandard. The following are examples of situations that might cause a loan or lease to be graded a “6”: • Cash flow deficiencies (losses) jeopardize future loan or lease payments. • Sale of non-collateral assets has become a primary source of loan or lease repayment. • The relationship has deteriorated to the point that sale of collateral is now the Company’s primary source of repayment, unless this was the original source of loan or lease repayment. • The borrower is bankrupt or for any other reason future repayment is dependent on court action. Grade 7 – Doubtful A loan or lease classified as doubtful has all the weaknesses inherent in one classified substandard with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of current existing facts, conditions, and values, highly questionable and improbable. A doubtful loan or lease has a high probability of total or substantial loss. Doubtful borrowers are usually in default, lack adequate liquidity or capital, and lack the resources necessary to remain an operating entity. Because of high probability of loss, nonaccrual accounting treatment will be required for doubtful loans and leases. Grade 8 – Loss Loans and leases classified loss are considered uncollectible and of such little value that their continuance as bankable assets is not warranted. This classification does not mean that the loan or lease has absolutely no recovery or salvage value, but rather that it is not practical or desirable to defer writing off the loan or lease even though partial recovery may be effected in the future.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements must maximize the use of observable inputs and minimize the use of unobservable inputs. There is a hierarchy of three levels of inputs that may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets or liabilities Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities Level 3 Unobservable inputs supported by little or no market activity that are significant to the fair value of the assets or liabilities

Investment Securities (Tables)

Investment Securities (Tables)	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	The amortized cost and approximate fair values, together with gross unrealized gains and losses, of securities are as follows: March 31, 2022 Amortized Gross Gross Fair Available for sale SBA Pools $ 8,232 $ — $ 342 $ 7,890 Federal agencies 15,000 — 1,154 13,846 State and municipal obligations 168,866 65 19,334 149,597 Mortgage-backed securities - government-sponsored enterprises (GSE) residential 156,309 6 11,021 145,294 Corporate obligations 10,500 — 292 10,208 358,907 71 32,143 326,835 Held to maturity State and municipal obligations 8,146 40 19 8,167 8,146 40 19 8,167 Total investment securities $ 367,053 $ 111 $ 32,162 $ 335,002 December 31, 2021 Amortized Gross Gross Fair Available for sale SBA Pools $ 8,691 $ 29 $ 107 $ 8,613 Federal agencies 15,000 — 274 14,726 State and municipal obligations 166,489 2,261 1,298 167,452 Mortgage-backed securities - government-sponsored enterprises (GSE) residential 164,629 712 2,831 162,510 Corporate obligations 4,250 2 28 4,224 Equity securities 13 — — 13 359,072 3,004 4,538 357,538 Held to maturity State and municipal obligations 9,041 147 2 9,186 9,041 147 2 9,186 Total investment securities $ 368,113 $ 3,151 $ 4,540 $ 366,724
Investments Classified by Contractual Maturity Date	The amortized cost and fair value of securities at March 31, 2022, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. Available for Sale Held to Maturity Amortized Fair Amortized Fair Within one year $ 1,159 $ 1,161 $ 1,196 $ 1,199 One to five years 8,668 8,564 4,862 4,868 Five to ten years 44,608 42,636 1,198 1,209 After ten years 148,163 129,180 890 891 202,598 181,541 8,146 8,167 Mortgage-backed securities –GSE residential 156,309 145,294 — — Totals $ 358,907 $ 326,835 $ 8,146 $ 8,167
Unrealized Gain (Loss) on Investments	The following tables show the Company’s investments by gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at March 31, 2022 and December 31, 2021: Description of March 31, 2022 Less Than 12 Months 12 Months or More Total Fair Unrealized Fair Unrealized Fair Unrealized Available-for-sale SBA Pools $ 2,486 $ 110 $ 4,582 $ 232 $ 7,068 $ 342 Federal agencies 9,292 708 4,554 446 13,846 1,154 State and municipal obligations 120,755 15,366 20,615 3,968 141,370 19,334 Mortgage-backed securities - GSE residential 123,280 8,535 20,548 2,486 143,828 11,021 Corporate obligations 8,458 292 — — 8,458 292 Total available-for-sale 264,271 25,011 50,299 7,132 314,570 32,143 Held-to-maturity State and municipal obligations 1,153 19 — — 1,153 19 Total temporarily impaired securities $ 265,424 $ 25,030 $ 50,299 $ 7,132 $ 315,723 $ 32,162 Description of December 31, 2021 Less Than 12 Months 12 Months or More Total Fair Unrealized Fair Unrealized Fair Unrealized Available-for-sale SBA Pools $ 2,838 $ 81 $ 3,214 $ 26 $ 6,052 $ 107 Federal agencies 14,726 274 — — 14,726 274 State and municipal obligations 74,235 1,044 7,809 254 82,044 1,298 Mortgage-backed securities - GSE residential 111,104 2,576 6,523 255 117,627 2,831 Corporate obligations 2,972 28 — — 2,972 28 Total available-for-sale 205,875 4,003 17,546 535 223,421 4,538 Held-to-maturity State and municipal obligations 421 2 — — 421 2 Total temporarily impaired securities $ 206,296 $ 4,005 $ 17,546 $ 535 $ 223,842 $ 4,540

Loans, Leases and Allowance (Ta

Loans, Leases and Allowance (Tables)	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	The following table shows the composition of the loan and lease portfolio at March 31, 2022 and December 31, 2021: March 31, December 31, Commercial mortgage $ 257,755 $ 261,202 Commercial and industrial 96,609 99,682 Construction and development 102,123 93,678 Multi-family 116,439 107,421 Residential mortgage 135,155 134,155 Home equity 8,393 7,146 Direct financing leases 130,451 126,762 Consumer 16,130 15,905 863,055 845,951 Less Allowance for loan and lease losses 12,317 12,108 Deferred loan fees 751 997 $ 849,987 $ 832,846
Financing Receivable, Allowance for Credit Loss	The following tables present the activity in the allowance for loan and lease losses for the three months ended March 31, 2022 and 2021: Balance, beginning of period Provision (credit) for losses Charge-offs Recoveries Balance, end of period Three Months Ended March 31, 2022: Commercial mortgage $ 4,742 $ (19) $ — $ 7 $ 4,730 Commercial and industrial 1,639 (97) — 15 1,557 Construction and development 2,286 148 — — 2,434 Multi-family 1,875 157 — — 2,032 Residential mortgage 263 (6) — 6 263 Home equity 29 6 — — 35 Leases 1,079 (15) (10) 10 1,064 Consumer 195 26 (24) 5 202 Total $ 12,108 $ 200 $ (34) $ 43 $ 12,317 Balance, beginning of period Provision (credit) for losses Charge-offs Recoveries Balance, end of period Three Months Ended March 31, 2021: Commercial mortgage $ 4,628 $ (208) $ — $ 6 $ 4,426 Commercial and industrial 2,270 (50) — 18 2,238 Construction and development 1,068 660 — — 1,728 Multi-family 1,039 3 — — 1,042 Residential mortgage 324 (2) — 6 328 Home equity 18 1 — — 19 Leases 1,054 75 (194) 94 1,029 Consumer 185 (79) (11) 54 149 Total $ 10,586 $ 400 $ (205) $ 178 $ 10,959 The following tables present the balance in the allowance for loan and lease losses and the recorded investment in loans and leases based on portfolio segment and impairment method as of March 31, 2022 and December 31, 2021: Allowance for loan and lease losses: Loans and leases: Individually evaluated for impairment Collectively evaluated for impairment Balance, March 31 Individually evaluated for impairment Collectively evaluated for impairment Balance, March 31 As of March 31, 2022: Commercial mortgage $ — $ 4,730 $ 4,730 $ 116 $ 257,639 $ 257,755 Commercial and industrial 298 1,259 1,557 978 95,631 96,609 Construction and development 750 1,684 2,434 4,900 97,223 102,123 Multi-family — 2,032 2,032 — 116,439 116,439 Residential mortgage — 263 263 117 135,038 135,155 Home equity — 35 35 — 8,393 8,393 Leases — 1,064 1,064 — 130,451 130,451 Consumer — 202 202 — 16,130 16,130 Total $ 1,048 $ 11,269 $ 12,317 $ 6,111 $ 856,944 $ 863,055 Allowance for loan and lease losses: Loans and leases: Individually evaluated for impairment Collectively evaluated for impairment Balance, December 31 Individually evaluated for impairment Collectively evaluated for impairment Balance, December 31 As of December 31, 2021: Commercial mortgage $ — $ 4,742 $ 4,742 $ 128 $ 261,074 $ 261,202 Commercial and industrial 299 1,340 1,639 995 98,687 99,682 Construction and development 750 1,536 2,286 4,900 88,778 93,678 Multi-family — 1,875 1,875 — 107,421 107,421 Residential mortgage — 263 263 119 134,036 134,155 Home equity — 29 29 — 7,146 7,146 Leases — 1,079 1,079 — 126,762 126,762 Consumer — 195 195 — 15,905 15,905 Total $ 1,049 $ 11,059 $ 12,108 $ 6,142 $ 839,809 $ 845,951
Financing Receivable Credit Quality Indicators	The following tables present the credit risk profile of the Company’s loan and lease portfolio based on rating category and payment activity as of March 31, 2022 and December 31, 2021: Pass Special Mention Substandard Doubtful Loss Total As of March 31, 2022: Commercial mortgage $ 252,647 $ 4,992 $ 116 $ — $ — $ 257,755 Commercial and industrial 88,227 7,032 1,350 — — 96,609 Construction and development 97,223 — 4,900 — — 102,123 Multi-family 116,439 — — — — 116,439 Residential mortgage 133,294 — 1,861 — — 135,155 Home equity 8,327 — 66 — — 8,393 Leases 130,308 — 97 46 — 130,451 Consumer 16,112 — 18 — — 16,130 Total $ 842,577 $ 12,024 $ 8,408 $ 46 $ — $ 863,055 Pass Special Mention Substandard Doubtful Loss Total As of December 31, 2021: Commercial mortgage $ 256,043 $ 5,031 $ 128 $ — $ — $ 261,202 Commercial and industrial 91,082 7,191 1,409 — — 99,682 Construction and development 88,778 — 4,900 — — 93,678 Multi-family 107,421 — — — — 107,421 Residential mortgage 132,223 — 1,932 — — 134,155 Home equity 7,097 — 49 — — 7,146 Leases 126,707 — 13 42 — 126,762 Consumer 15,883 — 22 — — 15,905 Total $ 825,234 $ 12,222 $ 8,453 $ 42 $ — $ 845,951
Schedule of Loans Classified by Aging Analysis	The following tables present the Company’s loan and lease portfolio aging analysis of the recorded investment in loans and leases as of March 31, 2022 and December 31, 2021: March 31, 2022 Delinquent Loans and Leases Current Total Total Loans 30-59 Days 60-89 Days 90 Days and Total Past Commercial mortgage $ 27 $ 418 $ 116 $ 561 $ 257,194 $ 257,755 $ — Commercial and industrial 387 570 367 1,324 95,285 96,609 — Construction and development 96 — 4,900 4,996 97,127 102,123 — Multi-family — — — — 116,439 116,439 — Residential mortgage 647 360 1,861 2,868 132,287 135,155 1,745 Home equity 120 — 31 151 8,242 8,393 31 Leases 86 152 — 238 130,213 130,451 — Consumer 88 59 18 165 15,965 16,130 18 Totals $ 1,451 $ 1,559 $ 7,293 $ 10,303 $ 852,752 $ 863,055 $ 1,794 December 31, 2021 Delinquent Loans and Leases Current Total Total Loans 30-59 Days 60-89 Days 90 Days and Total Past Commercial mortgage $ 29 $ — $ 128 $ 157 $ 261,045 $ 261,202 $ — Commercial and industrial 33 579 366 978 98,704 99,682 — Construction and development 55 96 4,900 5,051 88,627 93,678 — Multi-family — — — — 107,421 107,421 — Residential mortgage 710 174 1,932 2,816 131,339 134,155 1,813 Home equity 131 — 12 143 7,003 7,146 12 Leases 144 82 — 226 126,536 126,762 — Consumer 59 30 22 111 15,794 15,905 22 Totals $ 1,161 $ 961 $ 7,360 $ 9,482 $ 836,469 $ 845,951 $ 1,847
Impaired Financing Receivables	The following tables present the Company’s impaired loans and specific valuation allowance at March 31, 2022 and December 31, 2021: March 31, 2022 Recorded Unpaid Specific Impaired loans without a specific valuation allowance Commercial mortgage $ 116 $ 199 $ — Commercial and industrial 366 566 — Residential mortgage 117 243 — $ 599 $ 1,008 $ — Impaired loans with a specific valuation allowance Commercial and industrial $ 612 $ 648 $ 298 Construction and development 4,900 4,900 750 $ 5,512 $ 5,548 $ 1,048 Total impaired loans Commercial mortgage $ 116 $ 199 $ — Commercial and industrial 978 1,214 298 Construction and development 4,900 4,900 750 Residential mortgage 117 243 — Total impaired loans $ 6,111 $ 6,556 $ 1,048 December 31, 2021 Recorded Unpaid Specific Impaired loans without a specific valuation allowance Commercial mortgage $ 128 $ 199 $ — Commercial and industrial 367 566 — Residential mortgage 119 244 — $ 614 $ 1,009 $ — Impaired loans with a specific valuation allowance Commercial and industrial $ 628 $ 658 $ 299 Construction and development 4,900 4,900 750 $ 5,528 $ 5,558 $ 1,049 Total impaired loans Commercial mortgage $ 128 $ 199 $ — Commercial and industrial 995 1,224 299 Construction and development 4,900 4,900 750 Residential mortgage 119 244 — Total impaired loans $ 6,142 $ 6,567 $ 1,049 The following tables present the Company’s average investment in impaired loans and leases, and interest income recognized for the three months ended March 31, 2022 and 2021: Average Interest Three Months Ended March 31, 2022: Total impaired loans Commercial mortgage $ 122 $ 12 Commercial and industrial 987 7 Construction and development 4,900 — Residential mortgage 118 1 Total impaired loans and leases $ 6,127 $ 20 Average Interest Three Months Ended March 31, 2021: Total impaired loans Commercial mortgage $ 76 $ — Commercial and industrial 1,086 10 Construction and development 2,450 — Residential mortgage 180 2 Total impaired loans and leases $ 3,792 $ 12
Financing Receivable, Nonaccrual	The following table presents the Company’s nonaccrual loans and leases at March 31, 2022 and December 31, 2021: March 31, December 31, Commercial mortgage $ 116 $ 128 Commercial and industrial 978 995 Construction 4,900 4,900 Residential mortgage 117 119 Leases 46 42 $ 6,157 $ 6,184
Direct Financing Lease, Lease Income	The following lists the components of the net investment in direct financing leases: March 31, December 31, Total minimum lease payments to be received $ 143,600 $ 140,214 Initial direct costs 7,870 7,035 151,470 147,249 Less: Unearned income (21,019) (20,487) Net investment in direct finance leases $ 130,451 $ 126,762
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity	The following table summarizes the future minimum lease payments receivable subsequent to March 31, 2022: 2022 $ 41,326 2023 43,736 2024 31,387 2025 18,375 2026 7,858 Thereafter 918 $ 143,600

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring Basis	The following tables present the fair value measurements of assets recognized in the accompanying consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2022 and December 31, 2021: Fair Value Measurements Using Fair Quoted Prices Significant Significant March 31, 2022 Available-for-sale securities SBA Pools $ 7,890 $ — $ 7,890 $ — Federal agencies 13,846 — 13,846 — State and municipal obligations 149,597 — 149,597 — Mortgage-backed securities - GSE residential 145,294 — 145,294 — Corporate obligations 10,208 — 10,208 — $ 326,835 $ — $ 326,835 $ — Fair Value Measurements Using Fair Quoted Prices Significant Significant December 31, 2021 Available-for-sale securities SBA Pools $ 8,613 $ — $ 8,613 $ — Federal agencies 14,726 — 14,726 — State and municipal obligations 167,452 — 167,452 — Mortgage-backed securities - GSE residential 162,510 — 162,510 — Corporate obligations 4,224 — 4,224 — Equity securities 13 13 — — $ 357,538 $ 13 $ 357,525 $ —
Fair Value Measurements, Nonrecurring	The following table presents the fair value measurement of assets and liabilities measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2022 and December 31, 2021: Fair Value Measurements Using Fair Quoted Prices Significant Significant March 31, 2022 Impaired loans, collateral dependent $ 314 $ — $ — $ 314 Mortgage-servicing rights 1,572 — — 1,572 December 31, 2021 Impaired loans, collateral dependent $ 4,587 $ — $ — $ 4,587 Mortgage-servicing rights 1,647 — — 1,647
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The following tables present the fair value measurement of assets recognized in the accompanying consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2022 and December 31, 2021: Fair Value at March 31, Valuation Unobservable Range Collateral-dependent impaired loans $ 314 Appraisal Marketability discount 0 - 42% Mortgage-servicing rights $ 1,572 Discounted cash flow Discount rate 10% Fair Value at December 31, Valuation Unobservable Range Collateral-dependent impaired loans $ 4,587 Appraisal Marketability discount 0 - 39% Mortgage-servicing rights $ 1,647 Discounted cash flow Discount rate 10%
Schedule of Fair Value of Financial Instruments	The following tables present estimated fair values of the Company’s financial instruments at March 31, 2022 and December 31, 2021: Fair Value Measurements Using Carrying Quoted Prices Significant Significant March 31, 2022 Financial assets Cash and cash equivalents $ 19,576 $ 19,576 $ — $ — Available-for-sale securities 326,835 — 326,835 — Held-to-maturity securities 8,146 — 8,167 — Loans held for sale 583 — — 579 Loans and leases receivable, net 849,987 — — 849,749 Federal Reserve and FHLB stock 9,781 — 9,781 — Interest receivable 4,082 — 4,082 — Financial liabilities Deposits 909,495 — 907,798 — FHLB advances 182,000 — 184,801 — Interest payable 290 — 290 — Fair Value Measurements Using Carrying Quoted Prices Significant Significant December 31, 2021 Financial assets Cash and cash equivalents $ 23,038 $ 23,038 $ — $ — Available-for-sale securities 357,538 13 357,525 — Held-to-maturity securities 9,041 — 9,186 — Loans held for sale 558 — — 555 Loans and leases receivable, net 832,846 — — 833,975 Federal Reserve and FHLB stock 9,992 — 9,992 — Interest receivable 4,193 — 4,193 — Financial liabilities Deposits 900,175 — 900,528 — FHLB advances 180,000 — 185,065 — Interest payable 258 — 258 —

Earnings per Share (Tables)

Earnings per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents the computation of basic and diluted EPS for the periods indicated: Three Months Ended March 31, 2022 Three Months Ended March 31, 2021 Net income $ 3,018 $ 2,562 Shares outstanding for Basic EPS: Average shares outstanding 12,347,125 13,124,015 Less: average restricted stock award shares not vested 348,395 431,501 Less: average unearned ESOP Shares 951,205 1,005,311 Shares outstanding for Basic EPS 11,047,525 11,687,203 Additional Dilutive Shares 426,940 176,705 Shares outstanding for Diluted EPS 11,474,465 11,863,908 Basic Earnings Per Share $ 0.27 $ 0.22 Diluted Earnings Per Share $ 0.26 $ 0.22

Benefit Plans (Tables)

Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
Employee Stock Ownership Plan (ESOP) Disclosures	ESOP expense for the three months ended March 31, 2022 and 2021 was $226,000 and $183,000, respectively. March 31, December 31, Earned ESOP shares 144,302 130,775 Unearned ESOP shares 937,828 951,355 Total ESOP shares 1,082,130 1,082,130 Quoted per share price $ 17.06 $ 16.05 Fair value of earned shares $ 2,462 $ 2,099 Fair value of unearned shares $ 15,999 $ 15,269
Schedule of Restricted Stock Awards	The following table summarizes the restricted stock awards activity in the 2020 EIP during the three months ended March 31, 2022. Three Months Ended March 31, 2022 Number of Restricted Shares Weighted Average Grant Date Fair Value Non-vested, beginning of period 348,395 $ 10.56 Granted — — Vested — — Forfeited — — Non-vested, March 31, 2022 348,395 10.56
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The following table summarizes the stock option activity in the 2020 EIP during the three months ended March 31, 2022. Three Months Ended March 31, 2022 Number of Shares Weighted-Average Exercise Price Balance at beginning of period 1,050,961 $ 10.56 Granted — — Exercised — — Forfeited/expired — — Balance, March 31, 2022 1,050,961 10.56 Exercisable at end of period 200,503 $ 10.56
Fair Value Measurement Inputs and Valuation Techniques	The fair value of options granted is estimated on the date of the grant using a Black Scholes model with the following assumptions: April 1, 2021 Dividend yields 1.90 % Volatility factors of expected market price of common stock 26.98 % Risk-free interest rates 1.16 % Expected life of options 6.1 years
Schedule of Nonvested Share Activity	A summary of the status of the Company stock option shares as of March 31, 2022 is presented below. Shares Weighted Average Grant Date Fair Value Non-vested, beginning of year 850,458 $ 2.91 Vested — — Granted — — Forfeited — — Non-vested, March 31, 2022 850,458 $ 2.91

Basis of Presentation (Details)

Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Past due interest accrual period (in days)	90 days
Minimum satisfaction performance period of nonaccrual loans (in months)	6 months

Accounting Pronouncements (Deta

Accounting Pronouncements (Details)	3 Months Ended
	Mar. 31, 2022USD ($)loancontract	Mar. 31, 2021contract	Dec. 31, 2021USD ($)
Financing Receivable, Impaired [Line Items]
Number of loan and leases modified | contract	0	0
PPP Loans Outstanding	$ 849,987,070		$ 832,846,017
CARES Act
Financing Receivable, Impaired [Line Items]
Number of loan and leases modified | loan	0
Paycheck Protection Program
Financing Receivable, Impaired [Line Items]
PPP Loans issued	$ 38,200,000
PPP Loans Outstanding	$ 6,000,000

Investment Securities_ Marketab

Investment Securities: Marketable Securities (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Available for sale
Investment securities - available for sale	$ 326,835,054	$ 357,537,845
Equity securities, available-for-sale, amortized cost		13,000
Equity securities, available-for-sale, gross unrealized gain		0
Equity securities, available-for-sale, gross unrealized loss		0
Equity securities, available-for-sale, fair value		13,000
Equity securities
Debt securities, available-for-sale, and equity securities, amortized cost	358,907,000	359,072,000
Debt securities, available-for-sale, and equity securities, gross unrealized gains	71,000	3,004,000
Debt securities, available-for-sale, and equity securities, gross unrealized losses	32,143,000	4,538,000
Debt securities, available-for-sale, and equity securities, fair value	326,835,000	357,538,000
Held to maturity
Debt securities, held-to-maturity, amortized cost	8,146,327	9,040,825
Debt securities, held-to-maturity, accumulated unrecognized gain	40,000	147,000
Debt securities, held-to-maturity, accumulated unrecognized losses	19,000	2,000
Debt securities, held-to-maturity, fair value	8,167,000	9,186,000
Debt securities, available-for-sale and held-to-maturity, and equity securities, amortized cost	367,053,000	368,113,000
Debt securities, available-for-sale and held-to-maturity, and equity securities, gross unrealized gains	111,000	3,151,000
Debt securities, available-for-sale and held-to-maturity, and equity securities, gross unrealized losses	32,162,000	4,540,000
Debt securities, available-for-sale and held-to-maturity, and equity securities, fair value	335,002,000	366,724,000
SBA Pools
Available for sale
Debt securities, available for sale, amortized cost	8,232,000	8,691,000
Debt securities, available for sale, gross unrealized gain	0	29,000
Debt securities, available for sale, gross unrealized loss	342,000	107,000
Investment securities - available for sale	7,890,000	8,613,000
Federal agencies
Available for sale
Debt securities, available for sale, amortized cost	15,000,000	15,000,000
Debt securities, available for sale, gross unrealized gain	0	0
Debt securities, available for sale, gross unrealized loss	1,154,000	274,000
Investment securities - available for sale	13,846,000	14,726,000
State and municipal obligations
Available for sale
Debt securities, available for sale, amortized cost	168,866,000	166,489,000
Debt securities, available for sale, gross unrealized gain	65,000	2,261,000
Debt securities, available for sale, gross unrealized loss	19,334,000	1,298,000
Investment securities - available for sale	149,597,000	167,452,000
Held to maturity
Debt securities, held-to-maturity, amortized cost	8,146,000	9,041,000
Debt securities, held-to-maturity, accumulated unrecognized gain	40,000	147,000
Debt securities, held-to-maturity, accumulated unrecognized losses	19,000	2,000
Debt securities, held-to-maturity, fair value	8,167,000	9,186,000
Mortgage-backed securities - government-sponsored enterprises (GSE) residential
Available for sale
Debt securities, available for sale, amortized cost	156,309,000	164,629,000
Debt securities, available for sale, gross unrealized gain	6,000	712,000
Debt securities, available for sale, gross unrealized loss	11,021,000	2,831,000
Investment securities - available for sale	145,294,000	162,510,000
Corporate obligations
Available for sale
Debt securities, available for sale, amortized cost	10,500,000	4,250,000
Debt securities, available for sale, gross unrealized gain	0	2,000
Debt securities, available for sale, gross unrealized loss	292,000	28,000
Investment securities - available for sale	$ 10,208,000	$ 4,224,000

Investment Securities_ Investme

Investment Securities: Investments Classified by Contractual Maturity Date (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Amortized Cost
Debt securities, available-for-sale, amortized cost, within one year	$ 1,159,000
Debt securities, available-for-sale, amortized cost, one to five years	8,668,000
Debt securities, available-for-sale, amortized cost, five to ten years	44,608,000
Debt securities, available-for-sale, amortized cost, after ten years	148,163,000
Debt securities, available for sale, amortized cost	202,598,000
Debt securities, available for sale, amortized cost, mortgage backed securities -GSE residential	156,309,000
Fair Value
Debt securities, available-for-sale, fair value, within one year	1,161,000
Debt securities, available-for-sale, fair value, one to five years	8,564,000
Debt securities, available-for-sale, fair value, five to ten years	42,636,000
Debt securities, available-for-sale, fair value, after ten years	129,180,000
Debt securities, available for sale, fair value	181,541,000
Debt securities, available for sale, fair value, mortgage backed securities -GSE residential	145,294,000
Debt Securities, Held-to-maturity, Maturity, Amortized Cost, Net [Abstract]
Held-to-Maturity, amortized cost, within one year	1,196,000
Held-to-Maturity, amortized cost, one to five years	4,862,000
Held-to-Maturity, amortized cost, five to ten years	1,198,000
Held-to-Maturity, amortized cost, after ten years	890,000
Debt securities, held-to-maturity, amortized cost	8,146,000
Held-to-Maturity, amortized cost, mortgage backed securities -GSE residential	0
Debt Securities, Held-to-maturity, Maturity, Fair Value [Abstract]
Held-to-Maturity, fair value, within one year	1,199,000
Held-to-Maturity, fair value, one to five years	4,868,000
Held-to-Maturity, fair value, five to ten years	1,209,000
Held-to-Maturity, fair value, after ten years	891,000
Held-to-Maturity, fair value	8,167,000
Held-to-Maturity, fair value, mortgage backed securities -GSE residential	0
Equity securities
Debt securities, available-for-sale, and equity securities, amortized cost	358,907,000	$ 359,072,000
Debt securities, available-for-sale, and equity securities, fair value	326,835,000	357,538,000
Debt securities, held-to-maturity, amortized cost	8,146,327	9,040,825
Debt securities, held-to-maturity, fair value	$ 8,167,000	$ 9,186,000

Investment Securities_ Market_2

Investment Securities: Marketable Securities (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Securities pledged as security, carrying value	$ 120,074,000		$ 136,463,000
Proceeds from sales of securities available for sale	0	$ 0
Investments reported at less than historical cost, fair value	$ 315,723,000		$ 223,842,000
Investments reported at less than historical cost as percentage of total securities	94.00%		61.00%

Investment Securities_ Unrealiz

Investment Securities: Unrealized Gain (Loss) on Investments (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available-for-sale, less than 12 months, fair value	$ 264,271,000	$ 205,875,000
Available-for-sale, less than 12 months, unrealized loss	25,011,000	4,003,000
Available-for-sale, 12 months or more, fair value	50,299,000	17,546,000
Available-for-sale, 12 months or more, unrealized losses	7,132,000	535,000
Available-for-sale, total unrealized losses	314,570,000	223,421,000
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	32,143,000	4,538,000
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]
Temporarily impaired securities, less than 12 months, fair value	265,424,000	206,296,000
Temporarily impaired securities, less than 12 months, unrealized loss	25,030,000	4,005,000
Temporarily impaired securities, 12 months or more, fair value	50,299,000	17,546,000
Temporarily impaired securities, 12 months or more, unrealized losses	7,132,000	535,000
Temporarily impaired securities, total fair value	315,723,000	223,842,000
Temporarily impaired securities, total unrealized losses	32,162,000	4,540,000
SBA Pools
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available-for-sale, less than 12 months, fair value	2,486,000	2,838,000
Available-for-sale, less than 12 months, unrealized loss	110,000	81,000
Available-for-sale, 12 months or more, fair value	4,582,000	3,214,000
Available-for-sale, 12 months or more, unrealized losses	232,000	26,000
Available-for-sale, total unrealized losses	7,068,000	6,052,000
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	342,000	107,000
Federal agencies
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available-for-sale, less than 12 months, fair value	9,292,000	14,726,000
Available-for-sale, less than 12 months, unrealized loss	708,000	274,000
Available-for-sale, 12 months or more, fair value	4,554,000	0
Available-for-sale, 12 months or more, unrealized losses	446,000	0
Available-for-sale, total unrealized losses	13,846,000	14,726,000
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	1,154,000	274,000
State and municipal obligations
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available-for-sale, less than 12 months, fair value	120,755,000	74,235,000
Available-for-sale, less than 12 months, unrealized loss	15,366,000	1,044,000
Available-for-sale, 12 months or more, fair value	20,615,000	7,809,000
Available-for-sale, 12 months or more, unrealized losses	3,968,000	254,000
Available-for-sale, total unrealized losses	141,370,000	82,044,000
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	19,334,000	1,298,000
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract]
Held-to-maturity, less than 12 months, fair value	1,153,000	421,000
Held-to-maturity, less than 12 months, unrealized losses	19,000	2,000
Held-to-maturity, 12 months or more, fair value	0	0
Held-to-maturity, 12 months or more, unrealized losses	0	0
Held-to-maturity, total fair value	1,153,000	421,000
Held-to-maturity, total unrealized losses	19,000	2,000
Mortgage-backed securities - government-sponsored enterprises (GSE) residential
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available-for-sale, less than 12 months, fair value	123,280,000	111,104,000
Available-for-sale, less than 12 months, unrealized loss	8,535,000	2,576,000
Available-for-sale, 12 months or more, fair value	20,548,000	6,523,000
Available-for-sale, 12 months or more, unrealized losses	2,486,000	255,000
Available-for-sale, total unrealized losses	143,828,000	117,627,000
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	11,021,000	2,831,000
Corporate obligations
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available-for-sale, less than 12 months, fair value	8,458,000	2,972,000
Available-for-sale, less than 12 months, unrealized loss	292,000	28,000
Available-for-sale, 12 months or more, fair value	0	0
Available-for-sale, 12 months or more, unrealized losses	0	0
Available-for-sale, total unrealized losses	8,458,000	2,972,000
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ 292,000	$ 28,000

Loans, Leases and Allowance_ Sc

Loans, Leases and Allowance: Schedule of Accounts, Notes, Loans and Financing Receivable (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	$ 863,055,000	$ 845,951,000
Allowance for loan and lease losses	12,317,000	12,108,000	$ 10,959,000	$ 10,586,000
Deferred loan fees	751,000	997,000
Outstanding balance	849,987,070	832,846,017
Commercial mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	257,755,000	261,202,000
Commercial and industrial
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	96,609,000	99,682,000
Construction and development
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	102,123,000	93,678,000
Multi-family
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	116,439,000	107,421,000
Residential mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	135,155,000	134,155,000
Home equity
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	8,393,000	7,146,000
Direct financing leases
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	130,451,000	126,762,000
Consumer
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	$ 16,130,000	$ 15,905,000

Loans, Leases and Allowance_ Fi

Loans, Leases and Allowance: Financing Receivable, Allowance for Credit Loss (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Allowance for loan losses:
Allowance for loan losses, beginning balance	$ 12,108,000	$ 10,586,000
Provision (credit) for losses	200,000	400,000
Charge-offs	(34,000)	(205,000)
Recoveries	43,000	178,000
Allowance for loan losses, ending balance	12,317,000	10,959,000
Allowance for loan losses, individually evaluated for impairment	1,048,000		$ 1,049,000
Allowance for loan losses, collectively evaluated for impairment	11,269,000		11,059,000
Allowance for loan losses	12,317,000	10,959,000	12,108,000
Loans, individually evaluated for impairment	6,111,000		6,142,000
Loans, collectively evaluated for impairment	856,944,000		839,809,000
Total Portfolio Loans and Leases	863,055,000		845,951,000
Commercial mortgage
Allowance for loan losses:
Allowance for loan losses, beginning balance	4,742,000	4,628,000
Provision (credit) for losses	(19,000)	(208,000)
Charge-offs	0	0
Recoveries	7,000	6,000
Allowance for loan losses, ending balance	4,730,000	4,426,000
Allowance for loan losses, individually evaluated for impairment	0		0
Allowance for loan losses, collectively evaluated for impairment	4,730,000		4,742,000
Allowance for loan losses	4,730,000	4,426,000	4,742,000
Loans, individually evaluated for impairment	116,000		128,000
Loans, collectively evaluated for impairment	257,639,000		261,074,000
Total Portfolio Loans and Leases	257,755,000		261,202,000
Commercial and industrial
Allowance for loan losses:
Allowance for loan losses, beginning balance	1,639,000	2,270,000
Provision (credit) for losses	(97,000)	(50,000)
Charge-offs	0	0
Recoveries	15,000	18,000
Allowance for loan losses, ending balance	1,557,000	2,238,000
Allowance for loan losses, individually evaluated for impairment	298,000		299,000
Allowance for loan losses, collectively evaluated for impairment	1,259,000		1,340,000
Allowance for loan losses	1,557,000	2,238,000	1,639,000
Loans, individually evaluated for impairment	978,000		995,000
Loans, collectively evaluated for impairment	95,631,000		98,687,000
Total Portfolio Loans and Leases	96,609,000		99,682,000
Construction and development
Allowance for loan losses:
Allowance for loan losses, beginning balance	2,286,000	1,068,000
Provision (credit) for losses	148,000	660,000
Charge-offs	0	0
Recoveries	0	0
Allowance for loan losses, ending balance	2,434,000	1,728,000
Allowance for loan losses, individually evaluated for impairment	750,000		750,000
Allowance for loan losses, collectively evaluated for impairment	1,684,000		1,536,000
Allowance for loan losses	2,434,000	1,728,000	2,286,000
Loans, individually evaluated for impairment	4,900,000		4,900,000
Loans, collectively evaluated for impairment	97,223,000		88,778,000
Total Portfolio Loans and Leases	102,123,000		93,678,000
Multi-family
Allowance for loan losses:
Allowance for loan losses, beginning balance	1,875,000	1,039,000
Provision (credit) for losses	157,000	3,000
Charge-offs	0	0
Recoveries	0	0
Allowance for loan losses, ending balance	2,032,000	1,042,000
Allowance for loan losses, individually evaluated for impairment	0		0
Allowance for loan losses, collectively evaluated for impairment	2,032,000		1,875,000
Allowance for loan losses	2,032,000	1,042,000	1,875,000
Loans, individually evaluated for impairment	0		0
Loans, collectively evaluated for impairment	116,439,000		107,421,000
Total Portfolio Loans and Leases	116,439,000		107,421,000
Residential mortgage
Allowance for loan losses:
Allowance for loan losses, beginning balance	263,000	324,000
Provision (credit) for losses	(6,000)	(2,000)
Charge-offs	0	0
Recoveries	6,000	6,000
Allowance for loan losses, ending balance	263,000	328,000
Allowance for loan losses, individually evaluated for impairment	0		0
Allowance for loan losses, collectively evaluated for impairment	263,000		263,000
Allowance for loan losses	263,000	328,000	263,000
Loans, individually evaluated for impairment	117,000		119,000
Loans, collectively evaluated for impairment	135,038,000		134,036,000
Total Portfolio Loans and Leases	135,155,000		134,155,000
Home equity
Allowance for loan losses:
Allowance for loan losses, beginning balance	29,000	18,000
Provision (credit) for losses	6,000	1,000
Charge-offs	0	0
Recoveries	0	0
Allowance for loan losses, ending balance	35,000	19,000
Allowance for loan losses, individually evaluated for impairment	0		0
Allowance for loan losses, collectively evaluated for impairment	35,000		29,000
Allowance for loan losses	35,000	19,000	29,000
Loans, individually evaluated for impairment	0		0
Loans, collectively evaluated for impairment	8,393,000		7,146,000
Total Portfolio Loans and Leases	8,393,000		7,146,000
Leases
Allowance for loan losses:
Allowance for loan losses, beginning balance	1,079,000	1,054,000
Provision (credit) for losses	(15,000)	75,000
Charge-offs	(10,000)	(194,000)
Recoveries	10,000	94,000
Allowance for loan losses, ending balance	1,064,000	1,029,000
Allowance for loan losses, individually evaluated for impairment	0		0
Allowance for loan losses, collectively evaluated for impairment	1,064,000		1,079,000
Allowance for loan losses	1,064,000	1,029,000	1,079,000
Loans, individually evaluated for impairment	0		0
Loans, collectively evaluated for impairment	130,451,000		126,762,000
Total Portfolio Loans and Leases	130,451,000		126,762,000
Consumer
Allowance for loan losses:
Allowance for loan losses, beginning balance	195,000	185,000
Provision (credit) for losses	26,000	(79,000)
Charge-offs	(24,000)	(11,000)
Recoveries	5,000	54,000
Allowance for loan losses, ending balance	202,000	149,000
Allowance for loan losses, individually evaluated for impairment	0		0
Allowance for loan losses, collectively evaluated for impairment	202,000		195,000
Allowance for loan losses	202,000	$ 149,000	195,000
Loans, individually evaluated for impairment	0		0
Loans, collectively evaluated for impairment	16,130,000		15,905,000
Total Portfolio Loans and Leases	$ 16,130,000		$ 15,905,000

Loans, Leases and Allowance_ _2

Loans, Leases and Allowance: Financing Receivable Credit Quality Indicators (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	$ 863,055	$ 845,951
Commercial mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	257,755	261,202
Commercial and industrial
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	96,609	99,682
Construction and development
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	102,123	93,678
Multi-family
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	116,439	107,421
Residential mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	135,155	134,155
Home equity
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	8,393	7,146
Direct financing leases
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	130,451	126,762
Consumer
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	16,130	15,905
Pass
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	842,577	825,234
Pass | Commercial mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	252,647	256,043
Pass | Commercial and industrial
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	88,227	91,082
Pass | Construction and development
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	97,223	88,778
Pass | Multi-family
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	116,439	107,421
Pass | Residential mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	133,294	132,223
Pass | Home equity
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	8,327	7,097
Pass | Direct financing leases
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	130,308	126,707
Pass | Consumer
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	16,112	15,883
Special Mention
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	12,024	12,222
Special Mention | Commercial mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	4,992	5,031
Special Mention | Commercial and industrial
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	7,032	7,191
Special Mention | Construction and development
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Special Mention | Multi-family
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Special Mention | Residential mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Special Mention | Home equity
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Special Mention | Direct financing leases
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Special Mention | Consumer
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Substandard
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	8,408	8,453
Substandard | Commercial mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	116	128
Substandard | Commercial and industrial
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	1,350	1,409
Substandard | Construction and development
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	4,900	4,900
Substandard | Multi-family
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Substandard | Residential mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	1,861	1,932
Substandard | Home equity
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	66	49
Substandard | Direct financing leases
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	97	13
Substandard | Consumer
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	18	22
Doubtful
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	46	42
Doubtful | Commercial mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Doubtful | Commercial and industrial
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Doubtful | Construction and development
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Doubtful | Multi-family
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Doubtful | Residential mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Doubtful | Home equity
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Doubtful | Direct financing leases
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	46	42
Doubtful | Consumer
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss | Commercial mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss | Commercial and industrial
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss | Construction and development
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss | Multi-family
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss | Residential mortgage
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss | Home equity
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss | Direct financing leases
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	0	0
Loss | Consumer
Loans and Leases Receivable Disclosure [Line Items]
Portfolio loans	$ 0	$ 0

Loans, Leases and Allowance_ _3

Loans, Leases and Allowance: Schedule of Loans Classified by Aging Analysis (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financing Receivable, Past Due [Line Items]
Portfolio loans	$ 863,055	$ 845,951
Total Loans and Leases > 90 Days Accruing	1,794	1,847
Commercial mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	257,755	261,202
Total Loans and Leases > 90 Days Accruing	0	0
Commercial and industrial
Financing Receivable, Past Due [Line Items]
Portfolio loans	96,609	99,682
Total Loans and Leases > 90 Days Accruing	0	0
Construction and development
Financing Receivable, Past Due [Line Items]
Portfolio loans	102,123	93,678
Total Loans and Leases > 90 Days Accruing	0	0
Multi-family
Financing Receivable, Past Due [Line Items]
Portfolio loans	116,439	107,421
Total Loans and Leases > 90 Days Accruing	0	0
Residential mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	135,155	134,155
Total Loans and Leases > 90 Days Accruing	1,745	1,813
Home equity
Financing Receivable, Past Due [Line Items]
Portfolio loans	8,393	7,146
Total Loans and Leases > 90 Days Accruing	31	12
Direct financing leases
Financing Receivable, Past Due [Line Items]
Portfolio loans	130,451	126,762
Total Loans and Leases > 90 Days Accruing	0	0
Consumer
Financing Receivable, Past Due [Line Items]
Portfolio loans	16,130	15,905
Total Loans and Leases > 90 Days Accruing	18	22
30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Portfolio loans	1,451	1,161
30-59 Days Past Due | Commercial mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	27	29
30-59 Days Past Due | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Portfolio loans	387	33
30-59 Days Past Due | Construction and development
Financing Receivable, Past Due [Line Items]
Portfolio loans	96	55
30-59 Days Past Due | Multi-family
Financing Receivable, Past Due [Line Items]
Portfolio loans	0	0
30-59 Days Past Due | Residential mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	647	710
30-59 Days Past Due | Home equity
Financing Receivable, Past Due [Line Items]
Portfolio loans	120	131
30-59 Days Past Due | Direct financing leases
Financing Receivable, Past Due [Line Items]
Portfolio loans	86	144
30-59 Days Past Due | Consumer
Financing Receivable, Past Due [Line Items]
Portfolio loans	88	59
60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Portfolio loans	1,559	961
60-89 Days Past Due | Commercial mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	418	0
60-89 Days Past Due | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Portfolio loans	570	579
60-89 Days Past Due | Construction and development
Financing Receivable, Past Due [Line Items]
Portfolio loans	0	96
60-89 Days Past Due | Multi-family
Financing Receivable, Past Due [Line Items]
Portfolio loans	0	0
60-89 Days Past Due | Residential mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	360	174
60-89 Days Past Due | Home equity
Financing Receivable, Past Due [Line Items]
Portfolio loans	0	0
60-89 Days Past Due | Direct financing leases
Financing Receivable, Past Due [Line Items]
Portfolio loans	152	82
60-89 Days Past Due | Consumer
Financing Receivable, Past Due [Line Items]
Portfolio loans	59	30
90 Days and Over
Financing Receivable, Past Due [Line Items]
Portfolio loans	7,293	7,360
90 Days and Over | Commercial mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	116	128
90 Days and Over | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Portfolio loans	367	366
90 Days and Over | Construction and development
Financing Receivable, Past Due [Line Items]
Portfolio loans	4,900	4,900
90 Days and Over | Multi-family
Financing Receivable, Past Due [Line Items]
Portfolio loans	0	0
90 Days and Over | Residential mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	1,861	1,932
90 Days and Over | Home equity
Financing Receivable, Past Due [Line Items]
Portfolio loans	31	12
90 Days and Over | Direct financing leases
Financing Receivable, Past Due [Line Items]
Portfolio loans	0	0
90 Days and Over | Consumer
Financing Receivable, Past Due [Line Items]
Portfolio loans	18	22
Total Past Due
Financing Receivable, Past Due [Line Items]
Portfolio loans	10,303	9,482
Total Past Due | Commercial mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	561	157
Total Past Due | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Portfolio loans	1,324	978
Total Past Due | Construction and development
Financing Receivable, Past Due [Line Items]
Portfolio loans	4,996	5,051
Total Past Due | Multi-family
Financing Receivable, Past Due [Line Items]
Portfolio loans	0	0
Total Past Due | Residential mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	2,868	2,816
Total Past Due | Home equity
Financing Receivable, Past Due [Line Items]
Portfolio loans	151	143
Total Past Due | Direct financing leases
Financing Receivable, Past Due [Line Items]
Portfolio loans	238	226
Total Past Due | Consumer
Financing Receivable, Past Due [Line Items]
Portfolio loans	165	111
Current
Financing Receivable, Past Due [Line Items]
Portfolio loans	852,752	836,469
Current | Commercial mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	257,194	261,045
Current | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Portfolio loans	95,285	98,704
Current | Construction and development
Financing Receivable, Past Due [Line Items]
Portfolio loans	97,127	88,627
Current | Multi-family
Financing Receivable, Past Due [Line Items]
Portfolio loans	116,439	107,421
Current | Residential mortgage
Financing Receivable, Past Due [Line Items]
Portfolio loans	132,287	131,339
Current | Home equity
Financing Receivable, Past Due [Line Items]
Portfolio loans	8,242	7,003
Current | Direct financing leases
Financing Receivable, Past Due [Line Items]
Portfolio loans	130,213	126,536
Current | Consumer
Financing Receivable, Past Due [Line Items]
Portfolio loans	$ 15,965	$ 15,794

Loans, Leases and Allowance_ Im

Loans, Leases and Allowance: Impaired Financing Receivables (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Recorded Balance
Loans without a specific valuation allowance, recorded balance	$ 599	$ 614
Loans with a specific valuation allowance, recorded balance	5,512	5,528
Total impaired loans, recorded balance	6,111	6,142
Unpaid Principal Balance
Loans without a specific valuation allowance, unpaid principal balance	1,008	1,009
Loans with a specific valuation allowance, unpaid principal balance	5,548	5,558
Total impaired loans, unpaid principal balance	6,556	6,567
Loans with a specific valuation allowance	1,048	1,049
Commercial mortgage
Recorded Balance
Loans without a specific valuation allowance, recorded balance	116	128
Total impaired loans, recorded balance	116	128
Unpaid Principal Balance
Loans without a specific valuation allowance, unpaid principal balance	199	199
Total impaired loans, unpaid principal balance	199	199
Loans with a specific valuation allowance	0	0
Commercial and industrial
Recorded Balance
Loans without a specific valuation allowance, recorded balance	366	367
Loans with a specific valuation allowance, recorded balance	612	628
Total impaired loans, recorded balance	978	995
Unpaid Principal Balance
Loans without a specific valuation allowance, unpaid principal balance	566	566
Loans with a specific valuation allowance, unpaid principal balance	648	658
Total impaired loans, unpaid principal balance	1,214	1,224
Loans with a specific valuation allowance	298	299
Construction and development
Recorded Balance
Loans with a specific valuation allowance, recorded balance	4,900	4,900
Total impaired loans, recorded balance	4,900	4,900
Unpaid Principal Balance
Loans with a specific valuation allowance, unpaid principal balance	4,900	4,900
Total impaired loans, unpaid principal balance	4,900	4,900
Loans with a specific valuation allowance	750	750
Residential mortgage
Recorded Balance
Loans without a specific valuation allowance, recorded balance	117	119
Total impaired loans, recorded balance	117	119
Unpaid Principal Balance
Loans without a specific valuation allowance, unpaid principal balance	243	244
Total impaired loans, unpaid principal balance	243	244
Loans with a specific valuation allowance	$ 0	$ 0

Loans, Leases and Allowance_ _4

Loans, Leases and Allowance: Financing Receivable, Nonaccrual (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Financing Receivable, Past Due [Line Items]
Average Investment in Impaired Loans and Leases	$ 6,127	$ 3,792
Interest Income Recognized	20	12
Financing receivable, nonaccrual	6,157		$ 6,184
Commercial mortgage
Financing Receivable, Past Due [Line Items]
Average Investment in Impaired Loans and Leases	122	76
Interest Income Recognized	12	0
Financing receivable, nonaccrual	116		128
Commercial and industrial
Financing Receivable, Past Due [Line Items]
Average Investment in Impaired Loans and Leases	987	1,086
Interest Income Recognized	7	10
Financing receivable, nonaccrual	978		995
Construction and development
Financing Receivable, Past Due [Line Items]
Average Investment in Impaired Loans and Leases	4,900	2,450
Interest Income Recognized	0	0
Construction
Financing Receivable, Past Due [Line Items]
Financing receivable, nonaccrual	4,900		4,900
Residential mortgage
Financing Receivable, Past Due [Line Items]
Average Investment in Impaired Loans and Leases	118	180
Interest Income Recognized	1	$ 2
Financing receivable, nonaccrual	117		119
Leases
Financing Receivable, Past Due [Line Items]
Financing receivable, nonaccrual	$ 46		$ 42

Loans, Leases and Allowance_ Tr

Loans, Leases and Allowance: Troubled Debt Restructuring (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)loancontract	Mar. 31, 2021USD ($)contract	Dec. 31, 2021USD ($)
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of loan and leases modified | contract	0	0
Troubled debt restructuring, write-down	$ 0	$ 0
Troubled debt restructurings related allowance	48		$ 49
Troubled debt restructuring, subsequent default payments	$ 0
CARES Act
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of loan and leases modified | loan	0

Loans, Leases and Allowance_ Re

Loans, Leases and Allowance: Real Estate Owned and Foreclosed Real Estate Policy (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Foreclosed residential real estate with physical possession	$ 86	$ 27
Consumer mortgage loans secured by residential real estate properties in process of foreclosure	$ 885	$ 885

Loans, Leases and Allowance_ Di

Loans, Leases and Allowance: Direct Financing Lease, Lease Income (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Total minimum lease payments to be received	$ 143,600	$ 140,214
Initial direct costs	7,870	7,035
Direct financing lease revenue	151,470	147,249
Less: Unearned income	(21,019)	(20,487)
Net investment in direct finance leases	$ 130,451	$ 126,762

Loans, Leases and Allowance_ Le

Loans, Leases and Allowance: Leases Serviced for the Benefit of Others (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Leases serviced for the benefit of others	$ 0	$ 0
Recorded recourse obligation on leases sold with recourse	$ 0	$ 0

Loans, Leases and Allowance_ _5

Loans, Leases and Allowance: Schedule of Future Minimum Lease Payments (Details) $ in Thousands	Mar. 31, 2022USD ($)
Receivables [Abstract]
2022	$ 41,326
2023	43,736
2024	31,387
2025	18,375
2026	7,858
Thereafter	918
Payments to be received	$ 143,600

Fair Value of Financial Instr_3

Fair Value of Financial Instruments: Fair Value, Assets Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	$ 326,835	$ 357,538
Mortgage-backed securities - government-sponsored enterprises (GSE) residential
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	145,294	162,510
Corporate obligations
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	10,208	4,224
Equity securities
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure		13
SBA Pools
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	7,890	8,613
Federal agencies
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	13,846	14,726
State and municipal obligations
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	149,597	167,452
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	13
Quoted Prices in Active Markets for Identical Assets (Level 1) | Mortgage-backed securities - government-sponsored enterprises (GSE) residential
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate obligations
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity securities
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure		13
Quoted Prices in Active Markets for Identical Assets (Level 1) | SBA Pools
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Federal agencies
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | State and municipal obligations
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	326,835	357,525
Significant Other Observable Inputs (Level 2) | Mortgage-backed securities - government-sponsored enterprises (GSE) residential
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	145,294	162,510
Significant Other Observable Inputs (Level 2) | Corporate obligations
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	10,208	4,224
Significant Other Observable Inputs (Level 2) | Equity securities
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure		0
Significant Other Observable Inputs (Level 2) | SBA Pools
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	7,890	8,613
Significant Other Observable Inputs (Level 2) | Federal agencies
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	13,846	14,726
Significant Other Observable Inputs (Level 2) | State and municipal obligations
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	149,597	167,452
Significant Unobservable Inputs (Level 3)
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Unobservable Inputs (Level 3) | Mortgage-backed securities - government-sponsored enterprises (GSE) residential
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Unobservable Inputs (Level 3) | Corporate obligations
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Unobservable Inputs (Level 3) | Equity securities
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure		0
Significant Unobservable Inputs (Level 3) | SBA Pools
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Unobservable Inputs (Level 3) | Federal agencies
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Unobservable Inputs (Level 3) | State and municipal obligations
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	$ 0	$ 0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments: Fair Value Measurements, Nonrecurring (Details) - Fair Value, Nonrecurring - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Mortgage-servicing rights
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	$ 1,572	$ 1,647
Impaired loans, collateral dependent
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	314	4,587
Quoted Prices in Active Markets for Identical Assets (Level 1) | Mortgage-servicing rights
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Impaired loans, collateral dependent
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Other Observable Inputs (Level 2) | Mortgage-servicing rights
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Other Observable Inputs (Level 2) | Impaired loans, collateral dependent
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	0	0
Significant Unobservable Inputs (Level 3) | Mortgage-servicing rights
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	1,572	1,647
Significant Unobservable Inputs (Level 3) | Impaired loans, collateral dependent
Fair Value, Option, Quantitative Disclosures [Line Items]
Assets, fair value disclosure	$ 314	$ 4,587

Fair Value of Financial Instr_5

Fair Value of Financial Instruments: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details)	Mar. 31, 2022USD ($)	Dec. 31, 2021USD ($)
Fair Value, Option, Quantitative Disclosures [Line Items]
Mortgage-servicing rights	$ 1,572,386	$ 1,646,509
Significant Unobservable Inputs (Level 3)
Fair Value, Option, Quantitative Disclosures [Line Items]
Collateral-dependent impaired loans	314,000	4,587,000
Mortgage-servicing rights	$ 1,572,000	$ 1,647,000
Significant Unobservable Inputs (Level 3) | Discount rate | Discounted cash flow
Fair Value, Option, Quantitative Disclosures [Line Items]
Mortgage-servicing rights, Measurement Input	0.10	0.10
Minimum | Significant Unobservable Inputs (Level 3) | Marketability discount | Appraisal
Fair Value, Option, Quantitative Disclosures [Line Items]
Collateral-dependent impaired loans, measurement input	0	0
Maximum | Significant Unobservable Inputs (Level 3) | Marketability discount | Appraisal
Fair Value, Option, Quantitative Disclosures [Line Items]
Collateral-dependent impaired loans, measurement input	0.42	0.39

Fair Value of Financial Instr_6

Fair Value of Financial Instruments: Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Option, Quantitative Disclosures [Line Items]
Held-to-maturity securities	$ 8,167,000	$ 9,186,000
FHLB advances	182,000,000	180,000,000
Quoted Prices in Active Markets for Identical Assets (Level 1) | Financial assets
Fair Value, Option, Quantitative Disclosures [Line Items]
Cash and cash equivalents	19,576,000	23,038,000
Available-for-sale securities	0	13,000
Held-to-maturity securities	0	0
Loans held for sale	0	0
Loans and leases receivable, net	0	0
Federal Reserve and FHLB stock	0	0
Interest receivable	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Financial liabilities
Fair Value, Option, Quantitative Disclosures [Line Items]
Deposits	0	0
FHLB advances	0	0
Interest payable	0	0
Significant Other Observable Inputs (Level 2) | Financial assets
Fair Value, Option, Quantitative Disclosures [Line Items]
Cash and cash equivalents	0	0
Available-for-sale securities	326,835,000	357,525,000
Held-to-maturity securities	8,167,000	9,186,000
Loans held for sale	0	0
Loans and leases receivable, net	0	0
Federal Reserve and FHLB stock	9,781,000	9,992,000
Interest receivable	4,082,000	4,193,000
Significant Other Observable Inputs (Level 2) | Financial liabilities
Fair Value, Option, Quantitative Disclosures [Line Items]
Deposits	907,798,000	900,528,000
FHLB advances	184,801,000	185,065,000
Interest payable	290,000	258,000
Significant Unobservable Inputs (Level 3) | Financial assets
Fair Value, Option, Quantitative Disclosures [Line Items]
Cash and cash equivalents	0	0
Available-for-sale securities	0	0
Held-to-maturity securities	0	0
Loans held for sale	579,000	555,000
Loans and leases receivable, net	849,749,000	833,975,000
Federal Reserve and FHLB stock	0	0
Interest receivable	0	0
Significant Unobservable Inputs (Level 3) | Financial liabilities
Fair Value, Option, Quantitative Disclosures [Line Items]
Deposits	0	0
FHLB advances	0	0
Interest payable	0	0
Carrying Value | Financial assets
Fair Value, Option, Quantitative Disclosures [Line Items]
Cash and cash equivalents	19,576,000	23,038,000
Available-for-sale securities	326,835,000	357,538,000
Held-to-maturity securities	8,146,000	9,041,000
Loans held for sale	583,000	558,000
Loans and leases receivable, net	849,987,000	832,846,000
Federal Reserve and FHLB stock	9,781,000	9,992,000
Interest receivable	4,082,000	4,193,000
Carrying Value | Financial liabilities
Fair Value, Option, Quantitative Disclosures [Line Items]
Deposits	909,495,000	900,175,000
FHLB advances	182,000,000	180,000,000
Interest payable	$ 290,000	$ 258,000

Earnings per Share_ Schedule of

Earnings per Share: Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Net income (loss)	$ 3,018	$ 2,562
Average shares outstanding (in shares)	12,347,125	13,124,015
Less: average restricted stock award shares not vested (in shares)	348,395	431,501
Less: average unearned ESOP Shares (in shares)	951,205	1,005,311
Shares outstanding for Basic EPS (in shares)	11,047,525	11,687,203
Additional dilutive shares (in shares)	426,940	176,705
Shares outstanding for diluted EPS (in shares)	11,474,465	11,863,908
Basic earnings per share (in USD per share)	$ 0.27	$ 0.22
Diluted earnings per share (in USD per share)	$ 0.26	$ 0.22

Benefit Plans_ Narrative (Detai

Benefit Plans: Narrative (Details)	Apr. 01, 2021USD ($)$ / sharesshares	Oct. 01, 2020USD ($)$ / sharesshares	Jul. 01, 2020$ / sharesshares	Mar. 31, 2022USD ($)$ / sharesshares	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)$ / sharesshares	Jun. 30, 2021installment	Sep. 15, 2020shares
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution, percent of employees' gross pay				50.00%
Defined contribution plan, employer matching contribution, percent of match				6.00%
Defined contribution plan, administrative expense				$ 53,000	$ 52,000
Total ESOP shares (in shares) | shares			1,082,130	1,082,130		1,082,130
Quoted per share price (in USD per share) | $ / shares			$ 13.59	$ 17.06		$ 16.05
Value of ESOP shares				$ 12,744,530		$ 12,928,359
Share-based payment arrangement, expense				$ (226,121)	$ (182,705)
Granted (in shares) | shares				0
Grant date fair value (in USD per share) | $ / shares				$ 0
Restricted Stock
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Grant date fair value (in USD per share) | $ / shares				$ 0
2020 Equity Incentive Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Granted (in shares) | shares	8,000	1,095,657
Grant date fair value (in USD per share) | $ / shares	$ 13.86	$ 10.53
2020 Equity Incentive Plan | Stock option
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Common shares authorized (in shares) | shares								1,352,662
Stock options vesting installments | installment							5
Share-based payment arrangement, expense				$ 153,000
Tax benefit recognized				17,000
Unrecognized compensation expense				2,000,000
2020 Equity Incentive Plan | Restricted Stock
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Common shares authorized (in shares) | shares								541,065
Common shares awarded (in shares) | shares	4,000	449,086
Grant date fair value (in USD per share) | $ / shares	$ 13.86	$ 10.53
Total market value	$ 55,000	$ 4,700,000
Stock options vesting installments | installment							5
Share-based payment arrangement, expense				226,000
Tax benefit recognized				48,000
Unrecognized compensation expense				$ 3,000,000

Benefit Plans_ Employee Stock O

Benefit Plans: Employee Stock Ownership Plan (ESOP) Disclosures (Details) - USD ($)	Jul. 01, 2020	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Retirement Benefits [Abstract]
ESOP shares expense		$ 226,121	$ 182,705
Employee Stock Ownership Plan (ESOP), Shares in ESOP [Abstract]
Earned ESOP shares (in shares)		144,302		130,775
Unearned ESOP shares (in shares)		937,828		951,355
Total ESOP shares (in shares)	1,082,130	1,082,130		1,082,130
Quoted per share price (in USD per share)	$ 13.59	$ 17.06		$ 16.05
Fair value of earned shares		$ 2,462,000		$ 2,099,000
Fair value of unearned shares		$ 15,999,000		$ 15,269,000

Benefit Plans_ Restricted Stock

Benefit Plans: Restricted Stock Activity (Details) - Restricted Stock	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Number of Restricted Shares
Nonvested, beginning balance (in shares) | shares	348,395
Granted (in shares) | shares	0
Vested (in shares) | shares	0
Forfeited (in shares) | shares	0
Nonvested, ending balance (in shares) | shares	348,395
Weighted Average Grant Date Fair Value
Nonvested, beginning balance (in UDS per share) | $ / shares	$ 10.56
Granted (in USD per share) | $ / shares	0
Vested (in USD per share) | $ / shares	0
Forfeited (in USD per share) | $ / shares	0
Nonvested, ending balance (in UDS per share) | $ / shares	$ 10.56

Benefit Plans_ Stock Option Act

Benefit Plans: Stock Option Activity (Details)	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Number of Shares
Beginning balance (in shares) | shares	1,050,961
Granted (in shares) | shares	0
Exercised (in shares) | shares	0
Forfeited/expired (in shares) | shares	0
Ending balance (in shares) | shares	1,050,961
Exercisable at end of year (in shares) | shares	200,503
Weighted-Average Exercise Price
Balance at beginning of year (in USD per share) | $ / shares	$ 10.56
Grant date fair value (in USD per share) | $ / shares	0
Exercised (in USD per share) | $ / shares	0
Forfeited/expired (in USD per share) | $ / shares	0
Balance at end of year (in USD per share) | $ / shares	10.56
Exercisable at end of year (in USD per share) | $ / shares	$ 10.56

Benefit Plans_ Fair Value Measu

Benefit Plans: Fair Value Measurement of Stock Options (Details)	Apr. 01, 2021
Retirement Benefits [Abstract]
Dividend yields	1.90%
Volatility factors of expected market price of common stock	26.98%
Risk-free interest rates	1.16%
Expected life of options (in years)	6 years 1 month 6 days

Benefit Plans_ Stock Option Sta

Benefit Plans: Stock Option Status (Details)	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Shares
Non-vested, beginning of year (in shares) | shares	850,458
Vested (in shares) | shares	0
Granted (in shares) | shares	0
Forfeited (in shares) | shares	0
Non-vested, end of year (in shares) | shares	850,458
Weighted Average Grant Date Fair Value
Non-vested, beginning of year (in USD per share) | $ / shares	$ 2.91
Vested (in USD per share) | $ / shares	0
Granted (in USD per share) | $ / shares	0
Forfeited (in USD per share) | $ / shares	0
Non-vested, end of year (in USD per share) | $ / shares	$ 2.91

Subsequent Event (Details)

Subsequent Event (Details) - Subsequent Event	1 Months Ended
	May 13, 2022shares
Subsequent Event [Line Items]
Shares repurchased (in shares)	355,348
Remaining number of shares authorized to be repurchased (in shares)	554,014